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Pentraxin 3 (PTX3) is a vital regulator of innate immune function that has been shown to
counterregulate pro-inflammatory signaling and protect against the development of cardiovascular
disease (CVD). Less is known about how PTX3 may mitigate against CVD risk by regulating the
pro-inflammatory response at the cellular level. Therefore, this dissertation details four
manuscripts which aimed to examine the capacity of PTX3 to regulate the innate immune response
of peripheral blood mononuclear cells (PBMCs) isolated from healthy adults. Manuscript 1
examined the capacity of PTX3 to alter the inflammatory milieu following in vitro stimulation of
isolated PBMCs with the pro-inflammatory lipid palmitate. In addition, Manuscript 2 sought to
examine how participation in acute exercise, a powerful anti-inflammatory behavior that reduces
CVD risk, alters the inflammatory phenotype and response of mononuclear cells following ex vivo
stimulation with lipopolysaccharide (LPS). Manuscript 3 aimed to further elucidate the potential

impact of cardiorespiratory fitness on the capacity of PTX3 to stimulate an innate immune
response prior to and immediately following acute exercise in aerobically trained and untrained
individuals. Finally, Manuscript 4 investigated the impact of healthy aging on plasma PTX3
concentrations and its relationship with telomere length in middle-aged compared to young adults.
The capacity of isolated PBMCs to express a key cellular mechanism involved in maintaining
longer telomere lengths, human telomerase reverse transcriptase (hTERT), following cellular
stimulation with LPS, PTX3, and PTX3+LPS was also examined to address a mechanism that
might explain how persistent exposure of circulating immune cells to the age-related proinflammatory milieu contributes to the shortening of telomere lengths.

CHAPTER 1

INTRODUCTION

1

Cardiovascular disease (CVD) is the leading cause of death from non-communicable,
preventable diseases in adults across the globe (Lozano et al., 2012). In the United States alone,
over 40% of the adult population is expected to be diagnosed with CVD by 2030, accounting for
a $1.1 trillion burden to the healthcare system (Heidenreich et al., 2011). These staggering statistics
highlight the need to identify potential therapeutic targets that may attenuate the development and
pathology of CVD with increased age.
Pentraxin 3 (PTX3) is an acute phase protein that was initially observed to be expressed by
endothelial cells in response to stimulation with the pro-inflammatory cytokines tumor necrosis
factor alpha (TNF-α) and interleukin 1 beta (IL-1β) (Lee et al., 1990). PTX3 has since been shown
to be rapidly expressed by a variety of tissue and cell types following pro-inflammatory
stimulation, including the lungs, ovaries, thymus, brain, skeletal and cardiac muscle, visceral and
subcutaneous adipose tissue, vascular endothelial cells, fibroblasts, monocytes and monocytederived macrophages and dendritic cells, and maturing neutrophils (Alles et al., 1994; Lee et al.,
1994; Introna et al., 1996; Polentarutti et al., 2000; Abderrahim-Ferkoune et al., 2003; Doni et al.,
2006; Jallion et al., 2007; Osorio-Conles et al., 2011). In addition, PTX3 contains a 17-amino acid
long leader peptide that is essential for its cellular secretion into circulation, and contributes to
significant increases in plasma concentrations observed in response to systemic injection of the
gram-negative endotoxin lipopolysaccharide (LPS) (Lee et al., 1993; 1994). This resultant increase
in plasma PTX3 has contributed to its utilization as a biomarker of inflammatory perturbations
linked to CVD and all-cause mortality (Rolph et al., 2002; Jenny et al. 2009).
Although PTX3 is commonly associated with acute inflammatory insult and disease
pathology, Dias et al. (2001) utilized transgenic mice to show that the overexpression of PTX3
protects mice from death caused by systemic LPS injection. Furthermore, mice genetically
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modified not to express PTX3 present with increased systemic concentrations of pro-inflammatory
cytokines, advanced progression of vascular inflammation and atherosclerotic plaque formation,
and increased myocardial tissue damage following laboratory-induced heart damage (Salio et al.,
2008; Norata et al., 2009). However, the reintroduction of exogenous recombinant human
(rh)PTX3 in mice lacking the PTX3 gene is sufficient to reverse this phenotype, evidenced by
lower systemic pro-inflammatory cytokine concentrations (i.e., IL-6) and reduced damage to
cardiomyocytes (Salio et al., 2008). These findings suggest that elevated PTX3 concentrations
observed during pro-inflammatory disease may be a compensatory response necessary to regulate
an appropriate immune response during disease pathology.
At the cellular level, neutrophils are considered the primary cellular source of PTX3
(Jallion et al., 2007). More specifically, although mature peripheral neutrophils do not transcribe
PTX3 in response to cellular activation with LPS, their precursors synthesize PTX3 throughout
their maturation process and store ready-made concentrations that are released by mature
neutrophils in response to cellular activation or following exposure to LPS and other proinflammatory stimulants, including TNF-α (Imamura et al., 2007; Jallion et al., 2007). In addition,
Alles et al. (1994) have demonstrated that circulating monocytes are the only mature leukocyte to
express and secrete PTX3 in response to direct cellular stimulation. Until recently, it was unknown
how PTX3 may mediate the function of the innate immune system at the cellular level. However,
Deban et al. (2011) has demonstrated that PTX3 binds to the leukocyte adhesion molecule, Pselectin, as a mechanism to prevent the excess transmigration of leukocytes into the vascular
endothelium. Furthermore, PTX3 binds to and inhibits MD-2, a key molecule necessary for the
activation of the LPS-mediated pro-inflammatory response through its interaction with toll-like
receptor 4 (TLR4) on the surface of monocytes (Bozza et al., 2014). Likewise, exposure of
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circulating immune cells to elevated plasma PTX3 concentrations decreases cellular expression of
key intracellular molecules involved in the pro-inflammatory signaling cascade within monocytes
(Shiraki et al., 2016). As a result, PTX3 plays a vital role in regulating immune cell trafficking
into inflamed or damaged tissue, and simultaneously downregulates the production of proinflammatory cytokines, including TNF-α and IL-1β, and the chemokine monocyte
chemoattractant protein 1. In addition, PTX3 elicits the increased production of the antiinflammatory cytokines IL-10 and transforming growth factor beta (TGF-β) from neutrophil and
macrophage cell lines (Bozza et al., 2006; 2014; Shiraki et al., 2016). These findings support the
counterregulatory role of PTX3 in opposition to pro-inflammatory insult and suggest that
additional investigations regarding the role of PTX3 as a potential mediator of CVD-related proinflammation are warranted. Therefore, Manuscript 1 examined the capacity of PTX3 to alter the
inflammatory milieu following in vitro stimulation of isolated peripheral blood mononuclear cells
(PBMCs) with the pro-inflammatory lipid palmitate. Findings from this investigation suggest that
physiologically relevant concentrations of PTX3 (500 pg/mL) mediate an anti-inflammatory
response that may help prevent or counterregulate the development of CVD by enhancing immune
cellular production of IL-10.
Evidence exists that supports physical activity as a powerful anti-inflammatory behavior
that reduces the risk of age-related CVD pathology (Gleeson et al., 2011). In fact, Arem et al.
(2015) has recently demonstrated that any participation in physical activity on a weekly basis can
reduce early mortality by 20% and that engaging in at least 150 minutes of moderate-to-vigorous
intensity physical activity suggested by the American College of Sports Medicine and Centers for
Disease Control, procures a 31% reduction. Furthermore, plasma PTX3 concentrations have been
shown to be significantly elevated in aerobically trained compared to untrained men (Miyaki et
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al., 2011), and in physically active adults who were previously inactive (Miyaki et al., 2012a).
More importantly, elevated concentrations of plasma PTX3 in response to aerobic exercise training
are associated with rapid and significant improvements in cardiovascular health (Miyaki et al.,
2012b; Zempo-Miyaki et al., 2016). However, few studies have examined how physical activity
and cardiorespiratory fitness influence the innate immune response of isolated monocytes
following pro-inflammatory challenge, or how PTX3 may participate in this regulatory response.
Interestingly, our laboratory has recently demonstrated that participation in an acute bout of
submaximal exercise (75% of an individual’s maximal oxygen consumption [VO2max])
significantly increased plasma PTX3 concentrations for up to two hours during recovery from
exercise (Huang et al., 2014; Slusher et al. 2015; 2016a). To the contrary, the PBMC production
capacity of PTX3 following LPS stimulation was reduced and associated with the reduced
production of IL-6 and IL-10 in healthy, normal-weight individuals who were physically inactive
(Slusher et al., 2017a). Given that increased aerobic fitness, identified by an elevated VO2max, has
been closely linked to enhanced function of the immune system (Gleeson et al., 2011), Manuscript
2 sought to examine how participation in acute exercise alters the inflammatory phenotype and
response of mononuclear cells to ex vivo stimulation with LPS. Results from this investigation
support our previous finding that acute exercise appears to elicit a pro-inflammatory phenotype of
isolated monocytes, evidenced by the increased production of TNF-α and decreased production of
IL-6 and IL-10 (Slusher et al., 2017a). As a follow-up, Manuscript 3 sought to further elucidate
the potential impact of aerobic fitness on the capacity of PTX3 to stimulate an innate immune
response prior to and immediately following acute exercise. Results suggested that although
elevated levels of aerobic fitness reduce the capacity of mononuclear cells to produce PTX3, the
capacity of PTX3 to maintain the cellular production and release of IL-6 (a cytokine with known
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anti-inflammatory properties following exercise; Petersen and Pedersen, 2006) into the circulating
microenvironment following acute exercise is enhanced with increased fitness.
Finally, aging is accompanied by chronic, low-grade elevations in systemic inflammatory
cytokines, a phenomena known as inflamm-aging (Franceschi et al., 2000). While the sources of
age-related inflammation are numerous, the accumulation of centrally located visceral adipose
tissue occurring in the absence of weight gain or changes in body mass index (BMI) has been
shown be a hallmark of age and a significant mediator of age-related pro-inflammatory profiles
(Wu et al., 2007; Lumeng et al., 2011). As a result, elevated production and secretion of circulating
pro-inflammatory cytokines contribute to the increased risk of premature morbidity and mortality
from age-related diseases, including CVD and metabolic dysregulation (Kahn et al., 2006; Van
Gaal et al., 2006). Telomere lengths are an indicator of cellular age (Benetos et al., 2001), and
shorter telomere lengths are associated with increased concentrations of pro-inflammatory
cytokines and increased morbidity and mortality from CVD (Cawthon et al., 2003; Epel et al.,
2009; O’Donovan et al., 2011). Interestingly, elevated plasma PTX3 concentrations have recently
been shown to be associated with longer telomere lengths in healthy, middle-aged adults,
supporting the role of PTX3 as a biomarker of cellular aging. Therefore, Manuscript 4 investigated
the impact of healthy aging on plasma PTX3 concentrations and its relationship with telomere
length in middle-aged compared to young adults. In addition, the capacity of isolated PBMCs to
express a key cellular mechanism involved in maintaining longer telomere lengths, human
telomerase reverse transcriptase (hTERT), following cellular stimulation with LPS, PTX3, and
PTX3+LPS was examined to understand how persistent exposure of circulating immune cells to
the age-related pro-inflammatory milieu may contribute to the shortening of telomere lengths.
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CHAPTER 2

PENTRAXIN 3 IS AN ANTI-INFLAMMATORY PROTEIN ASSOCIATED WITH LIPIDINDUCED INTERLEUKIN 10 IN VITRO
Cytokine 2016; 86: 36-40. doi: 10.1016/j.cyto.2016.07.012

By: Slusher A.L.,a* Mischo A.B.,a Acevedo E.O.a

a

Department of Kinesiology and Health Sciences,
Virginia Commonwealth University, Richmond, VA, USA; * Corresponding Author
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ABSTRACT
Pentraxin 3 (PTX3) is an acute phase protein expressed in response to pro-inflammatory
stimuli during atherosclerosis. However, recent findings suggest that PTX3 is a counter-regulatory
protein which enhances the anti-inflammatory response. Objective: Therefore, the capacity of
PTX3 to alter the inflammatory milieu following in vitro stimulation of PBMCs with the proinflammatory lipid, palmitate, was examined. Methods: PBMCs from 17 healthy male donors
were isolated and cultured under four separate conditions; 200 µmol/L palmitate, a physiologically
relevant concentration of PTX3, in combination (pal + PTX3), and an unstimulated time-course
control. Results: Palmitate-induced production of the counter-regulatory protein PTX3 was
positively associated with the production of the anti-inflammatory cytokine interleukin 10 (IL-10)
following in vitro stimulation of human PBMCs. Furthermore, stimulation of PBMCs in vitro with
500 pg/mL PTX3 elicited a significantly greater increase in IL-10 production compared to the
palmitate stimulated conditions. However, PTX3 stimulation did not result in the production of
the pro-inflammatory cytokines IL-1β, IL-6, and tumor necrosis factor alpha, and when combined
with palmitate, did not alter the pro-inflammatory milieu from PBMCs in this study. Conclusion:
These findings provide evidence supporting the role of PTX3 as a mediator of the antiinflammatory response in physiologically relevant conditions, and suggests that PTX3 counter
regulates the development of atherosclerosis by enhancing the production of IL-10.

INTRODUCTION
Atherosclerosis is a dynamic inflammatory condition involving the progressive
accumulation of lipids and monocyte-derived macrophages within the vascular endothelium
(Moore and Tabas, 2011). A number of studies demonstrate that the local expression of proinflammatory cytokines, including interleukin 1 beta (IL-1β), IL-6, and tumor necrosis alpha
8

(TNF-α), exacerbate this pathogenic process (Libby et al., 2002; Kleemann et al., 2008). However,
elevated expression of the anti-inflammatory cytokine IL-10 is also observed in concert with
macrophage-derived pro-inflammatory cytokine production (Saraiva and O’Garra, 2010). IL-10
acts as a counter-regulatory protein that inhibits pro-inflammatory signaling and is atheroprotective in mice (Thüsen et al., 2001; Han et al., 2010). Therefore, the identification of potential
therapeutic agents that enhance the production of IL-10 may lead to treatment and prevention
strategies which inhibit the atherosclerotic process.
Pentraxin 3 (PTX3) is an acute phase reactant expressed by circulating monocytes and
resident macrophages in response to pro-inflammatory stimulation (Imamura et al., 2007; Doni et
al., 2008). A recent study by Shiraki et al. (2016) demonstrated that concentrations of PTX3 (10
ng/mL) observed during pathological conditions downregulate the production of pro-inflammatory
cytokines (IL-1β), and elicit the production of anti-inflammatory cytokines in response to proinflammatory stimulation of various macrophages cell lines. Unfortunately, although PTX3 is
associated with the production of IL-10 in animal models (Dias et al., 2001; Bozza et al., 2006;
2014), Shiraki et al. (2016) did not investigate IL-10 or utilize physiologically relevant
concentrations of circulating PTX3 on lipid-induced inflammation. The impact of PTX3 on IL-10
production in isolated human immune cells was also not examined.
Therefore, the purpose of this study was to examine the capacity of palmitate, an abundant
nutritional 16-carbon chain saturated fatty acid commonly utilized as an in vitro model of lipidinduced inflammation, to increase PTX3 production following in vitro stimulation in peripheral
blood mononuclear cells (PBMCs) from healthy male donors. In addition, the relationship of
palmitate-induced PTX3 and the anti-inflammatory (IL-10) and pro-inflammatory cytokine (IL1β, IL-6, and TNF-α) responses were assessed. It was hypothesized that the increased production
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of PTX3 following stimulation of PBMCs with palmitate would be positively associated with the
production of anti-inflammatory and pro-inflammatory cytokines.
Furthermore, PBMCs were stimulated in vitro with physiologically relevant concentrations
of circulating PTX3 typically observed in plasma under resting conditions to examine the antiinflammatory impact of PTX3. It was hypothesized that PTX3 would elicit the production of IL10, but not pro-inflammatory cytokines. Finally, PTX3 were added to PBMCs stimulated with
palmitate to examine the hypothesis that PTX3 would augment palmitate-induced IL-10
production and attenuate the production of IL-1β, IL-6, and TNF-α in vitro.

METHODS
Subject Participation
Seventeen healthy male subjects were recruited to participate in the study. Subjects arrived
at the laboratory at 6:00 am. Prior to participation, each subject provided informed consent and
completed a medical history questionnaire. Subjects were excluded from participation if they had
been previously diagnosed with inflammatory diseases/conditions (e.g., cardiovascular disease,
chronic kidney or liver disease, diabetes) or under the current administration of medication known
to alter inflammatory and/or metabolic profiles. Individuals who used tobacco products (cigarettes,
cigars, chewing tobacco) or consumed an average of ten or more standard alcoholic beverages per
week were also excluded. Finally, subject were instructed to undergo an overnight fast for at least
eight hours and to abstain from alcohol, caffeine intake, and intense physical activity for at least
24 hours. The study was approved by the University Institutional Review Board.

Preparation of PTX3 and Palmitate Solutions

10

Recombinant human PTX3 (R&D Systems, Minneapolis, MN, USA) was reconstituted
with phosphate buffered saline (PBS) (Fisher Scientific, Hampton, NH, USA) containing 0.1%
fatty acid free bovine serum albumin (BSA) (Sigma Aldrich, St. Louis, MO, USA). A final
concentration of 500 pg/mL was utilized for in vitro stimulation of PBMCs (described below).
This concentration has been previously shown to be physiologically similar to circulating
concentration of plasma PTX3 (Slusher et al., 2015), and was validated in our laboratory to be
sufficient to stimulate the production of the anti-inflammatory cytokine IL-10.
Palmitate (Sigma Aldrich, St. Louis, MO, USA) was prepared according to Lee and
colleagues (2012). In brief, palmitate was dissolved in 0.01M NaOH and solubilized at 70°C.
Prepared palmitate was conjugated with fatty acid free BSA in PBS for 15 minutes at 50°C,
resulting in a final molar ratio of 8:1. PBMCs were stimulated with a final concentration of 200
µmol/L, which has been previously shown to be sufficient to stimulate the production of proinflammatory cytokines (Shi et al., 2006).

Cell Culture for In Vitro PTX3 and Cytokine Production
A 10 mL whole blood sample was drawn from each subject’s anticubital vein using a 21G
butterfly needle into a tube containing K2 ethylenediaminetetraacetic acid (K2EDTA) (BD
Vacutainer, Franklin Lakes, NJ, USA). Whole blood samples were immediately centrifuged at
3000 RPM for 20 minutes at room temperature. The plasma supernatant was collected, centrifuged
at 10,000×g for 10 minutes to obtain platelet free plasma, and immediately stored at −80 °C in
cryogenic tubes in 500 μL aliquots for analysis of PTX3 using enzyme-linked immunosorbent
assay according to manufacture instructions (R&D Systems, Minneapolis, MN).
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The remaining buffy coat was collected and carefully layered over an equal volume of
Ficoll-Paque (ρ = 1.077 g/mL; Sigma-Aldrich, St. Louis, MO, USA) in a conical tube and
centrifuged at 400×g for 30 minutes at room temperature. The mononuclear cell layer was isolated,
and washed with saline three times. Pelleted PBMCs were suspended in 1 mL RPMI 1640 media,
counted manually by hemocytometer, adjusted to a final volume of 1.0×106 cells/mL, and cultured
in RPMI 1640 media (Invitrogen, Carlsbad, CA, USA) supplemented with 5% fetal bovine serum
(FBS), 1% penicillin, and 1% streptomycin (Life Technologies, Carlsbad, CA, USA) in a 96-well
cultured plate (Corning Incorporated, Corning, NY, USA). Plated PBMCs were stimulated with
palmitate (200 µmol/L), PTX3 (500 pg/mL), or in combination (pal + PTX3) and incubated at
37°C for 24 hours. Unstimulated samples served as a time-course control. Culture supernatants
were isolated and analyzed for PTX3, IL-1β, IL-6, IL-10, and TNF-α expression in duplicate by
enzyme-linked immunosorbent assay methods according to manufacturer’s instructions (R&D
Systems, Minneapolis, MN, USA).

Statistical Analyses
Data analyses were performed using the Statistical Package for the Social Sciences (SPSS
version 23.0). The effectiveness of palmitate stimulation on PTX3 production from PBMCs
compared to time-course controls was assessed utilizing an independent t-test. A one-way
ANOVA was conducted to compare the effects of each experimental culture condition (timecourse control, palmitate, PTX3, pal + PTX3) on inflammatory cytokine release from PBMCs.
Significant effects were further analyzed using Tukey’s post hoc comparisons. To examine the
relationships between PTX3 with pro- and anti-inflammatory cytokine production following
palmitate stimulation, Pearson’s correlation was utilized. Finally, the relationships between plasma
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PTX3 and the in vitro production of PTX3, pro- and anti-inflammatory cytokines under all
stimulatory conditions were examined by Pearson’s correlation. All data are presented as means ±
S.E.M. unless otherwise stated with statistical significance being defined as a P-value ≤ 0.05.

RESULTS
Descriptive statistics, including resting plasma PTX3 concentrations, are presented in
Table 1. Initial analysis revealed that palmitate elicited a significant increase in PTX3 compared
to time-course controls [t (7.882) = 32, p < 0.001; Figure 1]. In addition, significant differences
were observed among experimental culture conditions for IL-10 [F(3, 64) = 20.547, p < 0.001], IL1β [F(3, 64) = 31.296, p < 0.001], IL-6 [F(3, 64) = 35.461, p < 0.001], and TNF-α [F(3, 64) = 6.696, p =
0.001; Figures 2A-D]. Post hoc analysis further revealed that palmitate, compared to time-course
control conditions, elicited a significant increase in the anti-inflammatory cytokine IL-10 as well
as the pro-inflammatory cytokines IL-1β, IL-6, and TNF-α. In addition, a positive association was
observed between palmitate-induced PTX3 and palmitate-induced IL-10 (r = 0.538, p = 0.026),
whereas no associations were observed between the production of PTX3 and IL-1β, IL-6, or TNFα following palmitate stimulation (r = 0.394, p = 0.118; r = 0.357, p = 0.159; r = 0.012, p = 0.965,
respectively; Figures 3A-D), even after controlling for plasma PTX3 concentrations.
Stimulation of PBMCs with 500 pg/mL PTX3 in vitro resulted in a significant increase in
the anti-inflammatory cytokine IL-10 (p < 0.001) compared to time-course controls. However,
PTX3 did not elicit an increase in the production of pro-inflammatory cytokines IL-1β, IL-6, or
TNF-α. Statistical analyses further demonstrated that the production of IL-10 was greater
following PTX3 compared to palmitate stimulation (p = 0.003; Figure 2A). Conversely, palmitate
stimulation resulted in a greater production of the pro-inflammatory cytokines IL-1β and IL-6, and
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tended to elicit the greater production of TNF-α (p = 0.157) compared to PTX3 stimulation (see
figure 2B-D). However, the palmitate-induced anti-inflammatory response (increased IL-10) was
not augmented, and the pro-inflammatory response (increased IL-1β, IL-6, or TNF-α) was not
attenuated by the physiological concentration of PTX3 utilized in this study. Finally, plasma PTX3
concentrations were not associated with the in vitro production of PTX3 or pro- and antiinflammatory cytokines under any culture condition.

DISCUSSION
Results from this investigation demonstrate that lipid-induced production of the counterregulatory protein PTX3 is positively associated with the production of the anti-inflammatory
cytokine IL-10 following in vitro stimulation of human PBMCs. Furthermore, physiologically
relevant concentrations of PTX3 typically observed in plasma under resting conditions (500
pg/mL) stimulate a significantly greater increase in IL-10 production from PBMCs in vitro
compared to palmitate stimulated conditions. However, PTX3 stimulation does not elicit the
production of the pro-inflammatory cytokines IL-1β, IL-6, and TNF-α. These findings provide
evidence to support the role of PTX3 as a mediator of the anti-inflammatory response, and suggest
that PTX3 alters the inflammatory milieu associated with the development of atherosclerosis by
enhancing IL-10 production.
This is the first study to demonstrate that palmitate elicits the production and release of
PTX3 from human PBMCs in vitro. Circulating monocytes, which are the primary cell source
responsible for PTX3 production by PBMCs (Maina et al., 2009), serve as a biological sensor
reflective of tissue derived pathology (Bories et al., 2012). In addition, monocytes are widely
considered to be the prominent cellular component of the lipid-induced vascular innate immune
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response upon differentiation into resident macrophages (Pols et al., 2011). Therefore, the positive
association between palmitate-induce PTX3 and IL-10 production observed in this study suggests
that the enhanced lipid burden within the vascular endothelium during atherosclerosis increases
PTX3 and IL-10 production from resident monocyte-derived macrophages as a counter-regulatory
response to mediate pro-inflammation.
Previous studies have also demonstrated that supra-physiological concentrations of PTX3
enhance the cellular production of IL-10 (Bozza et al., 2006; 2014; D’Angelo et al., 2009), whereas
Shiraki et al. (2016) reported that stimulation of macrophages with pathological concentrations of
PTX3 (10 ng/mL) inhibit pro-inflammatory signaling and cytokine production, supporting the
notion that PTX3 is an anti-inflammatory protein. In corroboration of this posit, PTX3 increases
the production of IL-10 without eliciting the production of pro-inflammatory cytokines when
human PBMCs are stimulated in vitro with a physiologically relevant concentration of resting
PTX3. These findings indicate two main hypotheses: i) increased resting concentrations of PTX3
may pre-dispose circulating monocytes toward an anti-inflammatory phenotype prior to their
extravasation into the vascular endothelium, and ii) PTX3 production following inflammatory
insult may stimulate a reciprocal anti-inflammatory response that therapeutically polarizes
monocyte differentiation from an M1, pro-inflammatory, to an M2, anti-inflammatory,
macrophage phenotype (Sun et al., 2015).
It is important to note that the addition of PTX3 did not alter the palmitate-induced proinflammatory milieu from PBMCs in this study. Mechanistic studies demonstrate that palmitateinduced pro-inflammatory signaling occurs through Toll-like receptor (TLR) 4 engagement and
utilizes the myeloid differentiation factor-88 adaptor molecule to mediate activation of the nuclear
factor kappa B transcription factor (TLR4-MyD88-NF-κB pathway) (Lee et al., 2003; Shi et al.,
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2006). This is in contrast to PTX3-induced anti-inflammatory signaling, which occurs through
Toll-like receptor (TLR) 2, 3, and 4 engagement and depends on Toll/IL-1 domain-containing
adaptor molecule-mediated activation of the interferon-regulated factor-3 transcription factor
(TLR-TRIF-IRF3 pathway) (Bozza et al., 2006 2014). In addition, PTX3 induces Akt
phosphorylation, which not only increases IL-10 production, but inhibits the TLR4-mediated proinflammatory signaling and regulates NF-κB transcriptional activity in mononuclear cells (Guha
and Mackman, 2002; Saraiva and O’Garra, 2010; Shiraki et al., 2016). Compared to TRIF, TLRmediated activation of the MyD88 adaptor protein is the more rapid and robust cellular pathway
involved in inflammatory signaling (Kawai et al., 1999; Yamamoto et al., 2003). Therefore, the
inability of PTX3 to alter the inflammatory milieu in this study, contrary to the study by Shiraki et
al. (2016), may be due to the possibility that the dose of PTX3 that was utilized in this study was
insufficient to phosphorylate Akt to a level required to augment palmitate-mediated IL-10
production or inhibit pro-inflammatory signaling, and suggests that additional research is
warranted to determine the optimal physiological concentration of PTX3 necessary to counter proinflammatory signaling through Akt phosphorylation.
In conclusion, this investigation demonstrates that PTX3 production following in vitro
stimulation of PBMCs with palmitate may serve as a counter-regulatory protein which
preferentially facilitates an anti-inflammatory response characterized by elevated concentrations
of IL-10. Thus, these findings provide additional evidence supporting the anti-inflammatory and
athero-protective function of PTX3. Observations from this study are of particular interest for
obese populations who present with decreased concentrations of plasma PTX3 and monocytes that
are polarized towards an M1 phenotype (Yamasaki et al., 2009; Ogawa et al., 2010; Osorio-Conles
et al., 2011; Bories et al., 2012; Chu et al., 2012; Miyaki al., 2013; Witasp et al., 2014; Slusher et
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al., 2015; 2016a), and further examination of the aforementioned responses in obese populations
may provide additional insight into the clinical relevance of resting PTX3 concentrations.
Consequently, additional studies are warranted to investigate the optimal in vitro and in vivo
concentration of PTX3 necessary to correct inflammatory imbalances associated with PBMCs
from individuals at risk for atherosclerosis and to elucidate the molecular targets specific to PTX3induced IL-10 production. In addition, non-pharmaceutical intervention techniques which reduce
the risk for inflammatory-associated diseases by enhancing resting and transient concentrations of
circulating PTX3, such as acute and chronic aerobic exercise (Miyaki et al. 2011; Slusher et al.,
2015), should be considered.
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Table 1. Participant descriptive characteristics and
resting plasma PTX3 concentrations
Variable
n = 17
Age (y)
24.53 ± 3.97
BMI
22.1 ± 1.78
Weight (kg)
71.02 ± 8.25
Height (m)
1.79 ± 0.08
Plasma PTX3 (pg/mL)
2366.08 ± 1853.47
Note: Data are presented as means ± SD. BMI =
body mass index; PTX3 = pentraxin 3
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Figure 1. Stimulation of human PBMCs with palmitate in vitro induced a significantly greater
production of PTX3 compared to the time-course control condition. The * indicates a significant
difference between experimental culture conditions (p < 0.050). Data are presented as means ±
SEM.
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Figure 2. The production of anti-inflammatory (IL-10; panel A) and pro-inflammatory cytokines
(IL-1β, IL-6, and TNF-α; panel B-D) following the in vitro stimulation of PBMCs with palmitate,
PTX3, and palmitate + PTX3 (Pal + PTX3). The * indicates a significantly greater production of
inflammatory cytokines compared to time-course controls; the ¥ indicates a significantly greater
production of the anti-inflammatory cytokine IL-10 compared to palmitate and Pal + PTX3; the #
indicates a significantly greater production of pro-inflammatory cytokines IL-1β, IL-6, and TNFα compared to PTX3; (p < 0.050). Data are presented as means ± SEM.
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Figure 3. Associations of palmitate-induced PTX3 with palmitate-induced anti-inflammatory (IL10) and pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) following in vitro stimulation of
PBMCs. A positive association was observed between palmitate-induced PTX3 and palmitateinduced IL-10 (panel A). However, no associations were observed between the production of
PTX3 and IL-1β, IL-6, or TNF-α following palmitate stimulation (panel B-D), (p ≤ 0.050).
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CHAPTER 3

MAXIMAL EXERCISE ALTERS THE INFLAMMATORY PHENOTYPE AND RESPONSE
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ABSTRACT
Purpose: Monocytes express the CD14 receptor that facilitates lipopolysaccharide (LPS)
ligation to toll-like receptor 4 (TLR4) to elicit production of interleukin (IL)-6, IL-10, and tumor
necrosis factor alpha (TNF-α). However, pro-inflammatory conditions, such as strenuous exercise,
increase the percentage of monocytes expressing CD16, a receptor that enhances LPS stimulated
TNF-α production. Therefore, we examined whether maximal treadmill exercise would alter the
inflammatory phenotype of classical (CD14+/CD16-) and pro-inflammatory monocytes
(intermediate [CD14++/CD16+] and non-classical [CD14+/CD16++]), evidenced by changes in
TLR4, CD14, and CD16 receptor expression, and their inflammatory response to ex vivo LPS
stimulation. Methods: Human mononuclear cells from 25 male participants (age: 24.2 ± 4.0 yr.)
were isolated prior to and following exercise to assess TLR4, CD14, and CD16 expression by flow
cytometry and ex vivo production of LPS-stimulated inflammatory cytokines (IL-6, IL-10, and
TNF-α). Results: Exercise reduced the percentage of classical monocytes and increased the
percentage of intermediate and non-classical monocytes. In addition, TLR4 expression decreased
on classical and intermediate monocytes, but not the non-classical monocyte subset. Furthermore,
while CD14 expression decreased on all monocyte subsets, CD16 expression increased on
intermediate monocytes only. In parallel with these phenotypic changes, the inflammatory milieu
shifted towards a pro-inflammatory response following LPS stimulation (decreased IL-6 and IL10 and increased IL-6 to IL-10 ratio and TNF-α production). Conclusion: These findings
demonstrate that acute maximal exercise elicits a pro-inflammatory phenotype of isolated
monocytes exposed to LPS and highlight potential mechanisms that will help elucidate the role of
acute and chronic exercise on the innate immune response of circulating monocytes.
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INTRODUCTION
Monocytes help initiate the innate immune response necessary to protect the host from
“foreign” pathogens. Among peripheral blood mononuclear cells (PBMCs), monocytes are the
primary cell type that express toll-like receptor 4 (TLR4), a transmembrane, pattern recognition
receptor that stimulates the rapid production of inflammatory cytokines (interleukin-6 [IL-6], IL10 and tumor necrosis factor alpha [TNF-α]) in response to the Gram-negative lipopolysaccharide
endotoxin (LPS) (Pålsson-McDermott and O’Neil, 2004; Vaure and Liu, 2014). This activation
occurs via CD14, a cell surface receptor on monocytes that facilitates LPS ligation to TLR4 and
the subsequent inflammatory response (Wright et al., 1990; Kim and Kim, 2014). However,
monocytes are a heterogeneous population that are subdivided based on the co-expression of the
CD14 and CD16 receptors (Passlick et al., 1989). Classical monocytes express high levels of the
CD14 receptor, but no CD16 (CD14+bright/CD16-), and produce IL-6 (a pro- and anti-inflammatory
cytokine) and the anti-inflammatory cytokine IL-10 following LPS stimulation (Franenberger et
al., 1996; Petersen and Pedersen, 2006; Shalova et al., 2012). To the contrary, pro-inflammatory
monocytes express both CD14 and CD16 (CD14+/CD16+), and are further categorized as
intermediate (CD14+bright/CD16+dim) and non-classical (CD14+dim/CD16+bright) based upon CD14
and CD16 expression patterns. In addition, intermediate and non-classical monocytes express
elevated levels of TLR4 relative to classical monocytes (Simpson et al., 2009), and upon LPS
stimulation, intermediate monocytes produce IL-6, whereas the CD16 receptor interacts with LPS
ligation to TLR4 and enhances production of the pro-inflammatory cytokine TNF-α (Belge et al.,
2002; Pinheiro da Silva et al., 2007; 2008; Cros et al., 2012). Given that the inflammatory
phenotype of circulating monocytes predicts their innate immune function upon entry into tissue
as macrophages (Bories et al., 2012), interest in monocyte heterogeneity and the potential impact

24

of CD14 and CD16 receptor expression patterns on the LPS-induced inflammatory response has
received increased attention in the literature.
The perturbation of acute exercise provides a model for altering receptor expression
patterns on monocyte subsets, and for examination of the subsequent concomitant immune
response to LPS stimulation. For example, acute bouts of submaximal aerobic exercise increase
the percentage of pro-inflammatory monocytes in circulation (Wong et al., 2011; Radom-Aizik et
al., 2014). Additionally, while classical monocytes express reduced levels of TLR4 expression
during recovery from exercise, TLR4 surface expression has been shown to increase on both
intermediate and non-classical monocytes (Hong and Mills, 2008; Simpson et al., 2009; Booth et
al., 2010). Furthermore, Radom-Aizik et al. (2014) have revealed that monocytes demonstrate
elevated expression of numerous pro-inflammatory genes following acute intense cycling (82%
VO2peak). Although these findings suggest that acute exercise may also elicit a pro-inflammatory
phenotype of monocytes, none of the aforementioned studies examined the impact of acute
exercise on CD14 or CD16 receptor expression on each monocyte subset, which may provide
additional insight into their responsiveness to ex vivo stimulation with LPS. Similarly, while recent
studies have shown that acute exercise decreases the capacity of cultured whole blood samples and
individual monocytes to produce inflammatory cytokines following LPS stimulation (Dimitrov et
al., 2017; Durrer et al., 2017), no studies have stimulated isolated PBMCs with LPS. This
methodological approach removes the inflammatory contribution of neutrophils that express TLR4
and produce inflammatory cytokines following LPS stimulation of whole blood samples
(Dubravec et al., 1990), and may provide a more effective investigation of the cumulative
inflammatory status of monocytes exposed to elevated concentrations of LPS following exercise
(Selkirk et al., 2008). Therefore, the aim of this study was to examine the impact of acute exercise
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on the inflammatory phenotype of a standardized concentration of PBMCs and their
responsiveness to ex vivo LPS stimulation. It was hypothesized that the decreased percentage of
classical monocytes expressing lower levels of TLR4 following acute exercise would accompany
the reduced expression of CD14. In addition, the mobilization of pro-inflammatory monocytes
expressing elevated levels of TLR4 following acute exercise was hypothesized to accompany the
increased expression of CD14 and CD16. Finally, changes in the distribution of monocytes and
their phenotypic characteristics were hypothesized to shift the LPS-stimulated inflammatory
response towards a pro-inflammatory milieu, evidenced by the decreased production of IL-6 and
IL-10, and the elevated production of TNF-α following ex vivo stimulation with LPS. The ratio of
IL-6 to IL-10 was also examined prior to and immediately following exercise as an indicator of a
pro-inflammatory response (Taniguchi et al., 1999).

MATERIALS AND METHODS
Research participants
A total of twenty-five healthy male research participants (age 24.2 ± 4.0 yr.; body mass
index 21.96 ± 1.86 kg/m2; mean ± SD) were recruited and completed the study. Twelve subjects
were classified as aerobically trained (≥ 150 minutes of moderate to vigorous aerobic exercise per
week) and 13 subjects were classified as aerobically untrained (< 150 minutes of any moderate to
vigorous physical activity per week). Of note, female participants were excluded due to the
potential influence of gender on the LPS-stimulated inflammatory response following intense
exercise (Abbasi et al., 2013). Prior to participation, each research participant provided informed
consent and completed a medical history questionnaire and 7-day physical activity recall to verify
physical activity levels. Research participants were absent of any preexisting inflammatory
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disease(s) and were not currently under the administration of medication known to alter
inflammatory profiles. In addition, research participants were nonusers of tobacco products
(cigarettes, cigars, chewing tobacco) and consumed ten or less standard alcoholic beverages per
week on average. The University’s Institutional Review Board approved the study.

Exercise testing procedure
Research participants arrived at the laboratory at 6:00 o’clock in the morning following an
8-hour overnight fast and a 24-hour period without alcohol, caffeine intake, and intense physical
activity. The testing session began with the familiarization with all instruments and procedures,
followed by an assessment of height and weight utilizing standard medical equipment. Finally, an
assessment of maximal oxygen consumption (VO2max) was performed, utilizing a treadmill test
administered in gradation (absolute VO2max 3.75 ± 0.79 L O2 · min-1; relative VO2max 53.77 ± 10.34
mL O2 · kg-1 · min-1; time to completion 798.24 ± 167.27 seconds; mean ± SD). The administered
VO2max test was performed according to previously published methods (Slusher et al., 2017a). In
brief, the exercise protocol began with a 3-minute warm-up period at 4.83 kilometers per hour with
0% grade followed by 2-minute exercise stages. Speed was increased during the first 2-minute
stage to elicit 80% ± 5 beats per minute of the research participant’s age predicted maximal heart
rate (APMHR; 220-age), and allowed to reach steady-state during the second 2-minutes. Upon
completion of stage two, grade was increased 2% with each subsequent 2-minute stage, while
speed remained constant until the research participant reached voluntary exhaustion. VO2max was
determined using ParvoMedics Metabolic Measurement System (ParvoMedics, Sandy, UT, USA).
Heart rate (HR) and rating of perceived exertion (RPE) were assessed by HR monitors (Polar T31,
Polar Electro, Kempele, Finland) and the Borg RPE scale, respectively, and recorded during the
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final 15 seconds of every exercise stage. Rates of oxygen consumption (VO2) and carbon dioxide
production (VCO2) were also assessed and averaged every 15 seconds to calculate respiratory
exchange ratio (RER: VCO2/VO2). Criteria for attaining VO2max included a plateau in O2
consumption (defined as a failure to increase oxygen uptake by 150 mL/min with increased
workload) or three of the following: RER ≥ 1.1, HR within 10 bpm of research participant’s
APMHR, an RPE ≥ 19, and a blood lactate ≥ 8.0 mmol/L (assessed by finger prick; LactateScout+;
EKF Diagnostics; Cardiff, Wales).

Peripheral blood mononuclear cell isolation
A whole blood sample (10 mL) was drawn from each subject’s antecubital vein prior to
and immediately upon completion of exercise using a 21G butterfly needle into a tube containing
K2 ethylenediaminetetraacetic acid (K2EDTA) (BD Vacutainer, Franklin Lakes, NJ). Whole blood
samples collected prior to maximal exercise were kept at 4°C until the whole blood samples were
collected immediately following acute maximal exercise, then simultaneously centrifuged at 3000
rpm for 20 minutes at room temperature. The leukocyte buffy coat was collected and carefully
layered over an equal volume of Ficoll-Paque (ρ = 1.077 g/mL; Sigma-Aldrich, St. Louis, MO,
USA) in a conical tube and PBMC were further isolated by centrifugation at 400×g for 30 minutes
at room temperature. Isolated PBMCs were saline washed three times, suspended in 1 mL RPMI
1640 media, counted manually by hemocytometer, and adjusted to a final volume of 1.0×106
cells/mL.

Flow cytometry
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Aliquots of 1.0×106 cells/mL were washed, and pelleted cells were suspended in 100 µL
of phosphate-buffered saline (PBS) and incubated with 5 µL of Fc receptor blocking solution
(Biolegend, San Diego, CA, USA) for 10 minutes at room temperature to prevent non-specific
binding. Cells were labelled with either 2.5 µL of an fluorescein (FITC) conjugated anti-CD14
(IgG1, clone: HCD14; Biolegend), phycoerythrin (PE) conjugated anti-TLR4 (IgG2a, clone:
HTA125; Biolegend), and allophycocyanin (APC) conjugated anti-CD16 (IgG1, clone: 3G8;
Biolegend) monoclonal antibody (mAb) or 5 µL of an appropriate isotype control. The optimized
concentrations were determined prior to the study. Labelled cells incubated for 45-minute in the
dark at 4°C then fixed with 500 µL of 1% paraformaldehyde (Biolegend) for 30 minutes in the
dark at room temperature. Fixed cells were washed, suspended in 500 µL of PBS, and stored in
the dark at 4°C prior to analysis on a FACSCalibur flow cytometer within 24 hours using
CELLQuest Pro software (BD DBiosciences, San Jose, CA, USA).
Forward and 90° side scatter established primary gates for monocytes (Figure 1A), and
secondary gates were established against FITC and APC fluorescence to identify monocyte
subtypes based on CD14 and CD16 receptor expression patterns according to Mukherjee et al.
(2015) (Figure 1B). TLR4, CD14, and CD16 density was assessed as geometric mean fluorescent
intensity (GMFI) on CD14+, CD14+/CD16+ monocyte populations as well as on classical
(CD14+bright/CD16-),

intermediate

(CD14+bright/CD16+dim),

and

non-classical

(CD14+dim/CD16+bright) monocytes subsets. Negative gates were established using the appropriate
isotype controls to account for non-specific binding of Ig and to set the voltages for each
fluorescence detector filter. To exclude overlapping emission spectra and control for electronic
color compensation, the fluorescence of each conjugated mAb were analyzed in isolation using
one-color analysis.
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Assessment of LPS-induced inflammatory cytokines
Aliquots of 1.0×106 cells/mL were cultured in RPMI 1640 media (Invitrogen, Carlsbad,
CA, USA) supplemented with 5% fetal bovine serum, 1% penicillin, and 1% streptomycin (Life
Technologies, Carlsbad, CA, USA) in a 96-well cultured plate (Corning Incorporated, Corning,
NY, USA). Plated PBMCs were stimulated with LPS (10 ng/mL) and incubated at 37°C with 5%
CO2 for 24 hours as previously indicated (Slusher et al., 2017a). Unstimulated samples served as
a time-course control. Culture supernatants were isolated and analyzed for IL-6, IL-10, and TNFα in duplicate by enzyme-linked immunosorbent assay methods according to manufacturer’s
instructions (R&D Systems, Minneapolis, MN, USA).

Statistical analyses
The Statistical Package for the Social Sciences (SPSS version 24.0) performed all data
analysis. Notably, no differences in the monocyte phenotype or inflammatory response were
observed among trained and untrained subjects. Therefore, subsequent analyses were performed
in all subjects as a whole. Initial tests were performed to determine the presence of statistical
outliers using interquartile ranges, and values that fell outside the lower and upper limits were
objectively removed from analysis (Durrer et al., 2017). Assumptions of normality were examined
using a Shapiro-Wilk test, and non-normal data (p ≤ 0.05) were log transformed to reduce
skewness and kurtosis. Welch’s analysis of variance (ANOVA) examined differences in the
distribution of monocyte subsets, and TLR4 and CD14 expression patterns prior to exercise among
classical, intermediate and non-classical monocyte subsets, with significant differences assessed
with Games-Howell’s post hoc comparisons. Differences in CD16 expression patterns between
intermediate and non-classical monocytes were also examined using an independent t-test prior to
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exercise. Paired t-tests examined the impact of acute exercise on the percentage and the TLR4,
CD14, and CD16 expression density on classical, intermediate and non-classical monocyte
subsets. To examine differences in monocyte subset responses to acute exercise, Welch’s ANOVA
compared differences in the percent changes (pre to post exercise) in monocyte subset
distributions, and TLR4 and CD14 receptor expression patterns among classical, intermediate,
and non-classical monocyte subsets, with significant differences assessed with Games-Howell’s
post hoc comparisons. Likewise, an independent t-test compared differences in the percent change
in CD16 receptor expression between intermediate and non-classical monocyte subsets. In
addition, paired t-tests examined the impact of acute exercise on the ex vivo production of IL-10,
IL-6, and TNF-α following LPS stimulation. Finally, Pearson’s correlations were utilized to
examine the relationships between cardiorespiratory fitness (VO2max), the percent changes in the
phenotypic characteristics of monocytes (subset distributions and TLR4, CD14, and CD16
receptor expression), and their ex vivo production of inflammatory cytokines following acute
exercise. The Benjamini-Hochberg method (False Discovery Rate) was applied to correct for any
limitations related to performing multiple comparisons. Data are presented as means ± S.E.M.
unless otherwise stated with statistical significance defined as a P-value ≤ 0.05.

RESULTS
Impact of acute exercise on monocyte subset distribution
Following flow cytometry analysis, the percentage of monocytes among PBMCs were
unaltered in response to acute exercise relative to pre-exercise conditions (pre-exercise: 4.14 ±
1.99% vs. post: 4.09 ± 1.99%; p = 0.906). This finding suggests that adjusting for leukocytosis as
evident by changes in the absolute number of monocytes within the PBMC (1.0×106 cells/mL)
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population is not necessary for subsequent statistical analyses. Prior to exercise, there was a
significant difference in the percentage of monocyte subtypes (F [2, 40.844] = 2257.629, p ≤ 0.001;
Figure 2A). More specifically, classical (CD14+bright/CD16-) monocytes accounted for 81.85 ±
4.72% of the total monocyte population, whereas the intermediate (CD14+bright/CD16+dim) and nonclassical (CD14+dim/CD16+bright) monocyte subsets accounted for 4.68 ± 2.2% and 12.7 ± 4.90% of
the total monocyte population, respectively.
In response to acute maximal exercise, the percentage of monocytes considered classical
significantly decreased to 75.51 ± 6.88% of the total monocyte population (p ≤ 0.001), whereas
the intermediate and non-classical monocyte subsets significantly increased to 5.41 ± 2.57% (p =
0.017) and 18.18 ± 7.46% (p ≤ 0.001) of the total monocyte population, respectively. Finally, the
percent changes in monocyte subsets (pre to post exercise) were significantly different among all
monocyte subsets (F [2, 32.051] = 24.968; p ≤ 0.001; Figure 2B), indicating that while the percentage
of classical monocytes within the entire monocyte population decreased, the mobilization of
intermediate monocytes during acute exercise was less pronounced compared to non-classical
monocytes.

Impact of acute exercise on monocyte TLR4 expression
Prior to exercise, classical monocytes expressed a significantly lower TLR4 GMFI
compared to both intermediate and non-classical monocyte subsets (F [2, 45.221] = 52.544, p ≤ 0.001;
Figure 3A). In addition, post hoc analysis revealed no difference between the intermediate and
non-classical monocyte subsets (p = 0.363).
In response to acute maximal exercise, the TLR4 GMFI significantly decreased on the total
monocyte population compared to pre-exercise conditions (p ≤ 0.001). In addition, TLR4
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expression significantly decreased on classical monocytes (p = 0.001) and the intermediate subset
(p ≤ 0.001), whereas TLR4 expression on the non-classical subset remained unaltered (p = 0.079).
Similarly, while the percent change in TLR4 expression on classical monocytes was not different
compared to intermediate monocytes, TLR4 expression decreased significantly more on classical
and intermediate compared to the non-classical monocyte subset following exercise (F [2, 34.200] =
13.855; p ≤ 0.001; Figure 3B).

Impact of acute exercise on monocyte CD14 and CD16 surface expression
As expected, CD14 receptor expression was similar in classical and intermediate monocytes
prior to exercise, and both expressed significantly greater levels of CD14 compared to nonclassical monocytes (F [2, 35.757] = 1180.592, p ≤ 0.001; Figure 4A). In response to acute exercise,
CD14 receptor expression was significantly lower on the total monocyte population (p ≤ 0.001),
and associated subsets compared to pre-exercise conditions; classical (p ≤ 0.001), intermediate (p
= 0.014), and non-classical (p = 0.041). Furthermore, the percent change in CD14 receptor
expression was not different among classical, intermediate, and non-classical monocyte subsets
(F [2, 40.313] = 0.916, p = 0.408; Figure 4B).
Prior to exercise, CD16 receptor expression was significantly lower on intermediate
compared to non-classical monocytes (t

[46]

= -8.452, p ≤ 0.001; Figure 4C). In response to

exercise, CD16 significantly increased on the intermediate monocyte subsets (p = 0.036) and
remained unaltered on non-classical monocytes (p = 0.226). However, the percent change in CD16
expression between intermediate and non-classical monocyte subsets was not different (t [46] =
1.397, p = 0.169; Figure 4D).
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Impact of acute exercise on LPS-induced inflammatory cytokines
Compared to pre-exercise concentrations, ex vivo production of IL-6 and IL-10 from isolated
PBMCs stimulated with LPS were significantly decreased in response to acute exercise (t

[24]

=

3.268, p = 0.002; t [24] = 2.863, p = 0.005, respectively; Figures 5A and B). Conversely, the ratio
of IL-6 to IL-10 and the ex vivo production of the pro-inflammatory cytokine TNF-α were
significantly increased in response to acute exercise compared to pre-exercise levels (t [24] = 4.612,
p ≤ 0.001; t [24] = 2.128, p = 0.022, respectively; Figure 5C and D).

Relationships among VO2max, the percent changes in the phenotypic characteristics of
monocytes, and their ex vivo production of inflammatory cytokines following acute exercise
VO2max was negatively associated with the percent change in the proportion of intermediate
monocytes following acute exercise (r = -0.498, p = 0.013; Figure 6A). In addition, while VO2max
was negatively associated with the percent change in CD14 receptor expression on intermediate
monocytes following acute exercise (r = -0.484, p = 0.022; Figure 6B), VO2max tended to have a
positive association with the percent change in CD16 receptor expression on intermediate
monocytes (r = 0.322, p = 0.058). No other relationships among VO2max and the phenotypic
changes of monocytes or their ex vivo production of inflammatory cytokines were observed.
No relationships were observed among the phenotypic changes on classical or intermediate,
monocytes and changes in IL-6 and IL-10 production, the ratio of IL-6 to IL-10, or TNF-α
production, indicating the production of these inflammatory cytokines may have occurred
independent of the cardiorespiratory fitness and phenotypic changes observed on these monocyte
subsets following acute exercise. To the contrary, the percent increase in TNF-α production from
pre to immediately post exercise was positively associated with the percent change in the
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proportion of non-classical monocytes (r = 0.370, p = 0.038; Figure 6C) and negatively associated
with the percent change in CD14 receptor expression on non-classical monocytes (r = -0.417, p =
0.048; Figure 6D). No other relationships were observed among the phenotypic changes on nonclassical monocytes and changes in TNF-α production or other inflammatory cytokines.

DISCUSSION
This study examined the impact of the physical perturbation of acute maximal exercise on
monocyte subset distribution and TLR4, CD14, and CD16 receptor expression patterns that
determine the inflammatory phenotype of a standardized concentration of isolated monocytes, and
their subsequent inflammatory response to ex vivo stimulation with LPS. Observations from this
study support previous findings, demonstrating that acute exercise of various durations, intensities,
and modes, including a short bout of maximal exercise to exhaustion, reduces the percentage of
classical monocytes and increases the percentage of monocytes identified as intermediate and nonclassical (Steppich et al., 2000; Hong and Mills, 2008; Simpson et al., 2009; Booth et al., 2010;
Radom-Aizik et al., 2014). In addition, while other studies have shown that acute exercise reduces
TLR4 expression on the monocyte population as a whole (Lancaster et al., 2005; Oliveira and
Gleeson, 2010), data from the present study indicates that following acute maximal exercise, TLR4
expression is only lowered on classical and intermediate monocyte subsets and remains unaltered
on the non-classical subset. Furthermore, the present study demonstrates that CD14 expression
decreases on each monocyte subset, whereas CD16 expression increases on intermediate, but not
the non-classical monocyte subset, suggesting that acute exercise preferentially mobilizes proinflammatory monocytes expressing lower levels of CD14 and higher levels of CD16 receptor
expression. Likewise, given the associations with VO2max, these responses may be augmented in
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intermediate monocytes in individuals with elevated cardiorespiratory fitness levels. To examine
the potential impact of these phenotypic changes on innate immune function, isolated immune
cells were stimulated ex vivo with LPS. Compared to pre-exercise concentrations, the LPSstimulated production of the IL-6 (a pro- and anti-inflammatory cytokine) and the antiinflammatory cytokine IL-10 decreased, whereas the ratio of IL-6 and IL-10 and production of the
pro-inflammatory cytokine TNF-α increased. Thus, these findings indicate that acute maximal
exercise alters the cumulative inflammatory phenotype of monocytes towards a pro-inflammatory
milieu following ex vivo stimulation with LPS.
Chronic aerobic exercise training is considered anti-inflammatory and has been shown to
reduce the pathology of pro-inflammatory diseases, including cardiovascular disease and
metabolic dysfunction (Gleeson et al., 2011). In addition, the capacity of chronic aerobic exercise
training to reduce TLR4 expression and shift the inflammatory phenotype of isolated immune cells
towards an anti-inflammatory milieu has been supported (Timmerman et al., 2008; Gleeson et al.,
2011). While acute exercise has also recently been suggested to be anti-inflammatory (Durrer et
al., 2017), this notion has not been examined under a controlled culture environment using a
standardized concentration of isolated PBMCs (1.0×106 cells/mL), in which the monocytes are the
only cell type to respond to LPS stimulation (Wright et al., 1990). Early studies demonstrate that
TLR4 surface expression decreases on the total circulating monocyte population immediately
following prolonged submaximal exercise (1.5-2 hours in duration at 55% maximal work load or
75% VO2peak, respectively) (Lancaster et al., 2005; Oliveira and Gleeson, 2010). More recently,
studies have shown that TLR4 expression responds differently among monocyte subsets in
response to exercise. For example, TLR4 expression decreases on classical monocytes and
increases on the intermediate and non-classical monocyte subsets 1 hour into recovery from acute
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submaximal (45 minutes of running at 75% VO2max) and vigorous (60 km cycling time-trial)
exercise (Simpson et al., 2009; Booth et al., 2010). Interestingly, the present study observed a
decrease in TLR4 expression on classical and intermediate monocytes immediately following
maximal exercise, but not on the non-classical monocyte subset, suggesting that combinations of
exercise intensity and duration influence TLR4 expression differently among monocyte subsets.
The aforementioned findings suggest that the redistribution of monocyte subsets and the
altered TLR4 surface expression patterns following acute exercise transiently alters the
inflammatory phenotype of isolated monocytes in response to ex vivo stimulation with LPS.
Lancaster et al. (2005) were the first to examine the impact of acute aerobic exercise on the
inflammatory phenotype of monocytes. Researchers stimulated cultured whole blood samples with
LPS prior to and immediately following prolonged submaximal aerobic exercise (1.5 hours at 55%
peak work) in the heat (34° C), demonstrating that the LPS-induced production of intracellular IL6 within the total monocyte population was attenuated post exercise (Lancaster et al., 2005). The
inclination to interpret decreased IL-6 concentrations within monocytes as an anti-inflammatory
response (i.e., suppression of the pro-inflammatory response) may potentially be misleading. For
example, although elevated plasma IL-6 concentrations at rest are a biomarker of proinflammatory disease pathology (Van Gaal et al., 2006), Dr. B. K. Pedersen’s laboratory
(Copenhagen, Denmark) has demonstrated that systemic injection of IL-6 increases plasma IL-10
concentrations and inhibits the concomitant release of TNF-α into plasma following intravenous
injection of LPS into healthy humans (Starkie et al., 2003; Steensberg et al., 2003). Similarly, the
addition of IL-6 to cultured monocytes stimulated with LPS has been shown to downregulate TNFα production (Aderka et al., 1989; Fattori et al., 1994) and enhance the polarization of macrophages
towards and M2 (anti-inflammatory) phenotype by increasing anti-inflammatory cytokine
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production (including IL-10) (Fernando et al., 2014), lending to the consideration that IL-6
production from stimulated monocytes may potentially regulate the resultant inflammatory milieu
during LPS stimulation. Thus, while is unclear whether or not the increased ratio of IL-6 to IL-10
in the present study reflects a pro-inflammatory response as previously suggested (Taniguchi et
al., 1999), it is also possible that the attenuated net production of IL-6 that occurred independent
of changes in classical monocyte distribution of phenotypic expression may have contributed to
the observed suppression of IL-10. As a result, the decreased IL-6 and IL-10 may have enabled
the production of TNF-α from intermediate and non-classical monocyte subsets to increase.
Bories et al. (2012) have demonstrated that the inflammatory phenotype of circulating
monocytes determine their innate immune response upon infiltration and subsequent
differentiation into resident macrophages inside tissue. Interestingly, repeated bouts of high
intensity cycling exercise has been shown to enhance nuclear translocation of the nuclear factor
(NF)-κB transcription factor, potentially upregulating numerous genes associated with an
increased pro-inflammatory phenotype of isolated monocytes (Cuevas et al., 2005; Radom-Aizik
et al., 2014). However, while acute exercise may decrease the quantity of cytokines produced per
monocyte in response to LPS stimulation, as determined by intracellular staining of inflammatory
cytokines within individual monocytes, the number of monocytes that are capable of producing
cytokines in response to LPS stimulation has been shown to increase (Febbraio et al., 2002).
Therefore, the positive relationship between the increased production of TNF-α and the proportion
of non-classical monocytes supports the hypothesis that the mobilization of pro-inflammatory
monocytes directly contributes to the net elevation of LPS-induced TNF-α production observed
immediately following maximal exercise in the present study. Findings from this study further
indicate that suppression of the anti-inflammatory response in monocytes (i.e., decreased IL-6 and
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IL-10 or increased ratio of IL-6 to IL-10) occurs in favor of a pro-inflammatory phenotype (i.e.,
increased TNF-α), and may reflect a positive response that is necessary to facilitate debris
clearance from skeletal muscle damage (Chazaud et al., 2009), and to regulate vascular health and
function following acute exercise (Radom-Aizik et al., 2014).
It is important to note that this plausible explanation does not fully account for changes in
receptor expression patterns. For example, CD14 receptor expression decreased on both
intermediate and non-classical monocytes. Given that CD14 is considered necessary to initiate an
LPS-induced inflammatory response through TLR4 (Wright et al., 1990; Kim and Kim, 2014), it
is unknown how this response on non-classical monocytes would potentially contribute to the
elevated production of TNF-α. Nonetheless, non-classical monocytes are a more robust producer
of TNF-α in response to LPS stimulation compared to intermediate monocytes (Wong et al., 2011).
Thus, the enhanced mobilization of non-classical monocytes that maintained similar TLR4
expression levels, relative to the intermediate monocyte subset exhibiting lower TLR4 expression
levels, may have contributed to the elevated ex vivo production of TNF-α observed immediately
post exercise in this study. In addition, Pinheiro da Silva et al. (2007; 2008) demonstrate that CD16,
independent of immunoglobulin G, interacts with LPS ligation to TLR4 to augment cellular TNFα production. These findings indicate that the elevated expression of the CD16 receptor on
intermediate monocytes may have also helped facilitate the enhanced production of TNF-α
observed immediately following exercise. Finally, results from the present study suggest that
elevated cardiorespiratory fitness levels may mediate the mobilization and phenotypic
characteristics of intermediate monocyte subsets following acute exercise, potentially altering the
pro-inflammatory immune response observed in the present study. Future studies should therefore
consider targeting the function of specific receptors and include the utilization of polymyxin B, an
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antibiotic that prevents LPS binding to TLR4 as a mechanistic control to verify that the
inflammatory response is specific to LPS alone. Such studied would increase our understanding of
the biological significance of these phenotypic changes and their potential role in regulating the
innate immune response of monocytes following acute exercise in aerobically trained and
untrained populations.
In summary, the results from this investigation support the hypothesis that acute maximal
exercise alters the inflammatory phenotype of isolated monocytes exposed to ex vivo stimulation
with LPS. While additional research is necessary to differentiate the impact of acute exercise on
the inflammatory phenotype of each monocyte subset, the observed findings highlight potential
mechanistic targets that may elucidate the role of acute and chronic exercise on the inflammatory
phenotype of circulating monocytes. Results from such studies will further enhance our
understanding of monocyte involvement in the regulation of the systemic and tissue specific innate
immune response necessary for cardiovascular health.
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Figure 1. Representative flow cytometry dotplots demonstrating monocyte gating strategy. Panel
A: Forward and 90° side scatter established primary gates for monocytes (R1) from isolated
peripheral mononuclear cells. Panel B: Secondary gates were stablished against FITC-CD14 and
APC-CD16 to identify monocytes according to Mukherjee et al. (2015). Monocyte subsets were
identified according to CD14 and CD16 expression patterns. Classical: CD14+bright/CD16- (R2);
Intermediate: CD14+bright/CD16+dim (R3); Non-classical: CD14+dim/CD16+bright (R4).
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Figure 2. The percentage of monocytes identified as classical, intermediate, and non-classical
prior to and immediately post exercise (Panel A), and the percent changes in each monocyte
subsets from pre- to post-maximal exercise (Panel B). Note: # = difference in classical compared
to intermediate and non-classical monocytes; ¥ = difference in intermediate compared to nonclassical monocytes; * = difference compared to pre exercise (all p≤ 0.05). Data are presented as
means ± SEM.
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Figure 3. TLR4 expression on classical, intermediate, and non-classical prior to and immediately
post exercise (Panel A), and the percent change in TLR4 expression from pre- to post-maximal
exercise (Panel B). Note: # = difference in classical compared to intermediate and/or non-classical
monocytes; ¥ = difference in intermediate compared to non-classical monocytes; * = difference
compared to pre exercise (p≤ 0.05). Data are presented as means ± SEM.
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Figure 4. CD14 expression on classical, intermediate, and non-classical prior to and immediately
post exercise (Panel A), and the percent change in in CD14 expression from pre- to post-maximal
exercise (Panel B). CD16 expression on classical, intermediate, and non-classical prior to and
immediately post exercise (Panel C), and the percent change in in CD16 expression from pre- to
post-maximal exercise (Panel D). Note: # = difference in classical compared to non-classical
monocytes; ¥ = difference in intermediate compared to non-classical monocytes; * = difference
compared to pre exercise (p≤ 0.05). Data are presented as means ± SEM.
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Figure 5. Changes in LPS-stimulated production of IL-6 (Panel A), IL-10 (Panel B), the ratio of
IL-6 to IL-10 (Panel C), and TNF-α (Panel D) from isolated PBMCs prior to and immediately post
exercise. Note: * = difference compared to pre exercise (p≤ 0.05). Data presented at mean ± SEM.
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Figure 6. The association of relative VO2max and the percent change in the proportion of
intermediate monocytes (Panel A) and CD14 receptor expression (Panel B) and the association of
the percent change in the proportion of non-classical monocytes (Panel C) and CD14 receptor
expression (Panel D) with the percent change in LPS-stimulated TNF-α production from pre to
post maximal exercise.
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ABSTRACT
Purpose: Pentraxin 3 (PTX3) is a vital regulator of innate immune function. Although
plasma PTX3 concentrations are elevated with aerobic fitness, differences in the cellular function
of PTX3 remain unknown in aerobically trained and untrained subjects. Methods: Thirty
individuals (trained = 15 and untrained = 15) participated in a bout of maximal exercise to examine
ex vivo PTX3 production from isolated peripheral blood mononuclear cells (PBMCs) exposed to
LPS or palmitate. The capacity of PTX3 to regulate the ex vivo production of inflammatory
cytokines was also examined. Results: Elevated plasma PTX3 concentrations prior to exercise
were positively associated with the percent change in plasma PTX3 concentrations from pre to
immediately following acute exercise in all subjects, independent of cardiorespiratory fitness
(VO2max). In aerobically trained subjects only, the LPS- and palmitate-stimulated production of
PTX3 from isolated PBMCs were reduced post exercise and this response was associated with
lower plasma PTX3 concentrations at rest and in response to acute exercise. In addition, the PTX3stimulated production of the anti-inflammatory cytokines IL-10 and TGF-β1 decreased following
acute exercise, whereas IL-6 production remained unaltered in all subjects. However, the percent
change in IL-6 production was positively associated with VO2max in all subjects, and in trained
subjects only, positively associated with elevated plasma PTX3 concentrations at rest and in
response to acute exercise. Conclusion: These results suggest that aerobic fitness alters the
capacity of mononuclear cells to produce PTX3 following maximal exercise, and may enhance its
reciprocal role as a mediator of the innate immune response.

INTRODUCTION
Regular participation in aerobic exercise is well evidenced to reduce the pro-inflammatory
profiles associated with cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) (Kahn
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et al., 2006; Van Gall et al., 2006; Gleeson et al. 2011). However, the identification of a novel
circulating biomarker that may downregulate the inflammatory profiles associated with disease
pathology following chronic aerobic exercise remains relatively unknown. Interestingly, plasma
pentraxin 3 (PTX3) concentrations are elevated in aerobically trained compared to untrained
individuals (Miyaki et al., 2011; 2012), and are rapidly increased (i.e., 2-4 weeks) upon the
initiation of aerobic exercise training in previously sedentary individuals (Chu et al., 2012; ZempoMiyaki et al., 2016). More importantly, these elevated plasma PTX3 concentrations are directly
linked to the positive cardiovascular and metabolic adaptations that attenuate disease progression
following aerobic exercise training (Miaki et al., 2011 2012; Chu et al., 2012; Zempo-Miyaki et
al., 2016). In light of these findings, a closer examination of plasma PTX3 and its potential role in
regulating inflammation in aerobically trained individuals may provide insight into the
effectiveness of aerobic exercise as a behavioral strategy to reduce inflammatory disease, including
CVD and T2DM.
PTX3 is characterized as an acute phase reactant that is vital to the regulation of neutrophiland monocyte-mediated innate immune function (Norata et al., 2009; Deban et al., 2010; Bottazzi
et al., 2016). Specifically, early neutrophil progenitors synthesize PTX3 and store readily available
concentrations that are released into circulation following their activation as mature neutrophils
with endotoxin (lipopolysaccharide [LPS]) (Imamura et al., 2007; Jaillon et al., 2007). Monocytes
also produce and release PTX3 following exposure to LPS and the saturated fatty acid, palmitate
(Imamura et al., 2007; Shiraki et al., 2016; Slusher et al., 2016b). Consequently, PTX3
concentrations are elevated in concert with other pro-inflammatory cytokines (i.e., interleukin
[IL]-1β and tumor necrosis factor alpha [TNFα]), serving as a biomarker of CVD and T2DM
(Rolph et al., 2002 Jenny et al., 2009; Yang et al., 2014). However, evidence has recently
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elucidated that PTX3 attenuates the development of heart disease, the formation of atherosclerotic
plaques, and may help restore glucose homeostasis (Norata et al., 2009 Deban et al., 2010; Miyaki
et al., 2014; Escobar-Morreale et al., 2017; Weiss et al., 2017). In addition, PTX3 prevents the
excess transmigration of innate immune cells into the vascular endothelium during proinflammatory insult (Norata et al., 2009; Deban et al., 2010), inhibits the ligation of LPS to its
transmembrane receptor, toll-like receptor 4 (TLR4), and downregulates the intracellular signaling
pathways responsible for the transcription of pro-inflammatory cytokines by neutrophils and
monocytes (Bozza et al., 2014; Shiraki et al., 2016). Our laboratory and others have further shown
that PTX3 stimulates the production of interleukin-10 and other anti-inflammatory cytokines (i.e.,
transforming growth factor beta [TGF-β1]) from isolated monocytes (Shiraki et al., 2016; Slusher
et al., 2016b) and facilitates the transition of monocyte-derived macrophages from an M1, proinflammatory, to an M2, anti-inflammatory, phenotype (Sun et al., 2015). These findings suggest
that the anti-inflammatory capacity of PTX3 regulates the innate immune response and
substantiates the role of PTX3 as a counterregulatory protein that protects against the pathology of
pro-inflammatory disease, including CVD and T2DM.
Recently, our laboratory has also demonstrated that an acute bout of aerobic exercise (i.e.,
≥ 70% of an individual’s cardiorespiratory fitness level [VO2max]) increases plasma PTX3
concentrations in healthy, physically inactive individuals (Slusher et al., 2015; 2016a), yet the
LPS-stimulated ex vivo production of PTX3 from isolated peripheral blood mononuclear cells
(PBMCs) is significantly reduced immediately following acute exercise compared to pre-exercise
stimulations (Slusher et al., 2017a). Although these findings signify that the acute exercise-induced
plasma PTX3 response is independent of those produced by isolated PBMCs, this relationship has
not been examined in aerobically trained individuals. Therefore, the purpose of this investigation
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was twofold. Experiment 1: We first examined how aerobic fitness influences the relationship of
the exercise-induced plasma PTX3 response compared to the cellular production of PTX3 from
LPS-stimulated whole blood and isolated PBMCs and palmitate-stimulated PBMCs in trained and
untrained individuals. Experiment 2: We have also has recently shown that the reduced cellular
production of PTX3 following acute aerobic exercise is associated with the decreased production
of IL-6 and IL-10 in untrained individuals (Slusher et al., 2017a). As an extension of our past
investigation, isolated PBMCs were stimulated with physiologically relevant concentrations of
recombinant human PTX3 (rhPTX3; 500 pg/mL) to examine the likelihood that PTX3 mediates
the ex vivo production of IL-6, IL-10, and activated (act)TGF-β1 from PBMCs isolated from
aerobically trained and untrained individuals following acute exercise.

METHODS
Subjects
Thirty healthy aerobically trained (n = 15) and untrained (n = 15) subjects between 18 to
35 years old were recruited to participate in the study. Aerobically trained subjects were identified
as those who regularly participated in 150 or more minutes of moderate-to-vigorous intensity
aerobic exercise per week and untrained subjects were identified as those who participate in less
than 150 minutes of moderate intensity physical activity per week, including aerobic, anaerobic,
or resistance exercise, as determined by a 7-day physical activity recall (Craig et al., 2003). Prior
to participation, subjects provided their informed consent and completed a medical history
questionnaire. Subjects were excluded from participation if they had been previously diagnosed
with inflammatory diseases/conditions, such as cardiovascular disease, chronic kidney or liver
disease, diabetes, or were under the current administration of medication known to alter
inflammatory and/or metabolic profiles. In addition, subjects who were users of tobacco products
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(cigarettes, cigars, chewing tobacco), and/or consumed an average of ten or more standard
alcoholic beverages per week were excluded. The study was approved by the Institutional Review
Board.

Exercise Testing Procedures
Subjects arrived at the laboratory at 6:00 a.m. following an overnight fast of at least eight
hours. Subjects were also instructed to abstain from alcohol and caffeine intake for at least 24
hours and intense physical activity for at least 48 hours prior to the laboratory visit. Upon arrival,
each subject confirmed their adherence to the previously mentioned instructions and were
familiarized with all instruments and procedures. Immediately thereafter, height and weight were
assessed using basic medical devices to quantify the subject’s body mass index (BMI) by dividing
the subjects weight in kilograms by the square of their height in meters. In addition, waist and hip
circumferences were obtained by tape measure and body composition was assessed by
bioelectrical impedance (BIA) methods (OMRON HBF-308, Bannockburn, IL, USA). Next,
subjects were instructed to rest quietly for at least five minutes to obtain resting heart rate (HR)
and blood pressure (BP) using HR monitor (Polar T31, Polar Electro, Kempele, Finland) and
sphygmomanometer, respectively.
Subjects then participated in treadmill exercise test to assess maximal oxygen consumption
(i.e., VO2max) administered in gradation according to our laboratory’s previously described
protocol (Slusher et al., 2016a; 2017a). In brief, the test began with a 3-minute warm-up at 4.83
kilometers per hour and 0% grade. Following the warm-up, speed was increased to elicit 80% ± 5
bpm of the subject’s age predicted maximal HR (APMHR; 220-age) within the first 2-minute stage
(stage one). During the next two minutes (stage two), HR was allowed to reach steady-state. After
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the first four minutes, speed remained constant and the exercise intensity was elevated by
increasing grade 2% every 2 minutes until the subject reached volitional exhaustion. In addition,
HR and rating of perceived exertion (RPE; Borg’s 15-point scale) were recorded during the final
15 seconds of every exercise stage. VO2max was determined using the ParvoMedics Metabolic
Measurement System (ParvoMedics, Sandy, UT, USA), with rates of oxygen consumption (VO2)
and carbon dioxide production (VCO2) assessed and averaged every 15 seconds to calculate
respiratory exchange ratio (RER: VCO2/VO2). Criteria for attaining VO2max included a plateau in
O2 consumption (defined as a failure to increase oxygen uptake by 150 mL/min with increased
workload) or three of the following secondary criteria: RER ≥ 1.15, HR within 10 bpm of subject’s
APMHR, blood lactate ≥ 8.0 mmol/L (assessed be finger prick; LactateScout+; EKF Diagnostics;
Cardiff, Wales), and an RPE ≥ 19.

Experiment 1
Assessment of Plasma PTX3 Concentrations
A 10 mL whole blood sample was drawn from each subject’s antecubital vein prior to
participation and immediately upon completion of the maximal exercise test using a 21G butterfly
needle into a tube containing K2 ethylenediaminetetraacetic acid (K2EDTA) (BD Vacutainer,
Franklin Lakes, NJ, USA). Whole blood samples were immediately centrifuged at 3000 rpm for
20 minutes at room temperature. The plasma supernatant was collected and centrifuged at 10,000g
for 10 minutes at 4°C to obtain platelet-free plasma for the analysis of PTX3 in duplicate by
enzyme-linked immunosorbent assay (ELISA) methods (R&D Systems, Minneapolis, MN, USA).

Cell Culture for ex vivo PTX3 Production from Whole Blood
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Two 6 mL whole blood samples were also collected prior to and immediately upon
completion of the maximal exercise test as described above. One whole blood sample from each
time point was stimulated with 10 ng/mL of LPS (Phenol extraction from E. coli 055:B5, SigmaAldrich, St. Louis, MO, USA) and incubated at 37°C with 5% CO2 for 3 hours and manually
inverted every 15 minutes. The unstimulated whole blood samples served as a time-course control
for each time point. Following the incubation period, whole blood samples were centrifuged at
3000 rpm for 20 minutes at room temperature. The plasma supernatant was collected and
centrifuged at 10,000g for 10 minutes at 4°C for the analysis of PTX3 by ELISA methods.

Cell Culture for ex vivo PTX3 Production from Isolated PBMCs
A 10 mL whole blood sample was collected prior to and immediately upon completion of
the maximal exercise test and immediately centrifuged (3000 rpm for 20 minutes at room
temperature). Following removal of the plasma supernatant, the leukocyte buffy coat was isolated
and carefully layered over an equal volume of Ficoll-Paque (ρ = 1.077 g/mL; Sigma-Aldrich, St.
Louis, MO, USA) in a conical tube and centrifuged at 400g for 30 minutes at room temperature.
The isolated PBMCs layer was washed three times with saline, suspended in 1 mL RPMI 1640
media (Invitrogen, Carlsbad, CA, USA), and manually counted by hemocytometer. Counted
PBMCs were then adjusted to a final volume of 1.0x106 cells/mL in RPMI 1640 media
supplemented with 5% fetal bovine serum, 1% penicillin, and 1% streptomycin (Life
Technologies, Carlsbad, CA, USA), aliquoted equally in a 96-well culture plate (Corning
Incorporated, Corning, NY, USA), and stimulated with LPS (10 ng/mL) or palmitate (200 µmol/L;
Sigma-Aldrich, St. Louis, MO, USA) as previously described (Slusher et al., 2016b; 2017a).
Unstimulated cell samples served as a time-course control for each time point. Following a 24 hour
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incubation period at 37°C with 5% CO2, culture supernatants were isolated for the analysis of
PTX3.

Experiment 2
Cell Culture for ex vivo PTX3-Mediated Inflammatory Cytokine Production from Isolated PBMCs
Separate samples of isolated PBMCs (isolated as described above) were exposed to 500
pg/mL of rhPTX3 (R&D Systems, Minneapolis, MN, USA) containing 0.1% fatty acid free bovine
serum albumin (Sigma-Aldrich, St. Louis, MO, USA) as previously described (Slusher et al.,
2016b). Unstimulated cell samples served as a time-course control for each time point. Following
a 24-hour incubation period at 37°C with 5% CO2, culture supernatants were isolated and analyzed
for IL-6, IL-10, and actTGF-β1 by ELISA methods (R&D Systems, Minneapolis, MN, USA). Of
note, actTGF-β1 concentrations were undetectable in three subjects and therefore not included in
the data analysis.

Statistical Analyses
Data analysis was performed using the Statistical Package for the Social Sciences (SPSS
version 23.0). Independent t-tests were conducted to compare anthropometric and
cardiorespiratory profiles between aerobically trained and untrained subjects. Experiment 1: A two
group (trained and untrained) by two time point (pre- and immediately post-maximal exercise)
repeated measures analysis of variance (rmANOVA) was used to examine the effects of acute
aerobic exercise on plasma PTX3, LPS-stimulated PTX3 production from whole blood and
isolated PBMCs, and palmitate-stimulated PTX3 production from isolated PBMCs. If the
Mauchly’s test indicated violation of the sphericity assumption, the degrees of freedom were
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corrected by the Greenhouse-Geisser estimates. In addition, Pearson’s correlations were utilized
to examine the relationships among cardiorespiratory fitness (relative VO2max) and plasma PTX3
and culture-stimulated PTX3 concentrations prior to (resting conditions) and in response to
maximal exercise (percent change from pre- to immediately post-maximal exercise). Experiment
2: The impact of maximal exercise on the PTX3-stimulated production of inflammatory cytokines
(IL-6, IL-10, and actTGF-β1) in aerobically trained and untrained subjects was assessed by
rmANOVA, and the potential relationships of these variables with relative VO2max and plasma
PTX3 concentrations were examined with Pearson’s correlations. All data are presented as means
± S.E.M. unless otherwise stated with statistical significance being defined as a P-value ≤ 0.05.

RESULTS
Subject Anthropometric Characteristics and Cardiovascular Measures
Baseline anthropometric characteristics and cardiovascular measures between trained and
untrained subjects are reported in Table 1. Although no differences were observed in
anthropometric characteristics, aerobically trained subjects presented with lower resting HR (t
[22.877] =

-3.816, p = 0.001) and exhibited significantly greater absolute and relative VO2max values

(t [28] = 7.431, p < 0.001; t [28] = 11.437, p < 0.001, respectively) compared to untrained subjects.

Experiment 1
Plasma PTX3 Concentrations
Prior to participation in the maximal exercise protocol, no difference was observed in
plasma PTX3 concentrations in aerobically trained compared to untrained subjects. In response to
maximal exercise, repeated measures ANOVA revealed that plasma PTX3 concentrations
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significantly increased to a similar extent in both aerobically trained and untrained subjects (F [1,
28] =

10.500, p = 0.003; Figure 1A). In addition, elevated concentrations of plasma PTX3 prior to

exercise were positively associated with the plasma PTX3 response to maximal exercise (r = 0.428,
p = 0.018; Figure 1B). Finally, no associations were observed with plasma PTX3 concentrations
and indices of cardiorespiratory fitness.

PTX3 Production Following Ex Vivo Stimulation of Whole Blood and Isolated PBMCs
Three separate culture experiments were performed to examine the relationship of plasma
PTX3 concentrations with the cellular production of PTX3 from leukocytes stimulated with proinflammatory stimuli. Prior to exercise, no differences were observed in the production of PTX3
between aerobically trained and untrained subjects following LPS stimulation of whole blood and
isolated PBMCs, or following palmitate stimulation of isolated PBMCs. In response to maximal
exercise, the production of PTX3 from LPS stimulated whole blood was increased to a similar
extent in both aerobically trained and untrained subjects (F [1, 27] = 4.524, p = 0.043; Figure 2A),
whereas the production of PTX3 tended to decrease more in aerobically trained compared to
untrained subjects following LPS stimulation of isolated PBMCs (F [1, 28] = 2.935, p = 0.098; Figure
2B). Likewise, there was a significant decrease in palmitate stimulated PTX3 production in
aerobically trained compared to untrained subjects following maximal exercise (F [1, 28] = 6.404, p
= 0.017; Figure 2C). Notably, no differences were observed in the constitutive release of PTX3
from any culture sample at rest or in response to maximal exercise, as assessed in the unstimulated
time course control samples (data not shown).
To further assess how cardiorespiratory fitness may have influenced these responses, the
relationship of relative VO2max and culture-stimulated PTX3 production under all three conditions
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were assessed prior to and in response to maximal exercise (percent change from pre- to
immediately post-maximal exercise). As a result, no associations were observed between relative
VO2max and culture-stimulated PTX3 production prior to participation in maximal exercise. To the
contrary, relative VO2max was negatively associated with the percent change in LPS-stimulated
PTX3 production from whole blood (r = -0.641, p < 0.001; Figure 2D), but not isolated PBMCs (r
= -0.272, p = 0.146; Figure 2E). In addition, relative VO2max was negatively associated with the
percent change in palmitate-stimulated PTX3 production from isolated PBMCs (r = -0.406, p =
0.026; Figure 2F).
Next, the associations of plasma PTX3 with the cellular production of PTX3 exposed to
pro-inflammatory stimuli was assessed prior to and immediately following maximal exercise.
Consistent with our previous reports, plasma PTX3 concentrations appear independent to those
produced by whole blood and isolated PBMCs following exposure to pro-inflammatory stimuli
(Slusher et al., 2016b; 2017a). However, given the apparent role of cardiorespiratory fitness
(relative VO2max) as a mediator of cellular PTX3 production, the relationship of plasma PTX3 and
culture-stimulated PTX3 concentrations were examined independently in aerobically trained and
untrained subjects. No relationships were observed in plasma PTX3 concentrations with LPSstimulated PTX3 production from whole blood samples in aerobically trained or untrained
subjects. To the contrary, plasma PTX3 concentrations were positively associated with the percent
change in LPS- and palmitate-stimulated PTX3 production from PBMCs at rest (r = 0.610, p =
0.016; r = 0.621, p = 0.014, respectively; Figures 3A and B) and in response to maximal exercise
(r = 0.539, p = 0.038; r = 0.578, p = 0.024, respectively; Figure 3C and D) in aerobically trained,
but not untrained, subjects, even after controlling for relative VO2max.
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Experiment 2
PTX3-Stimulated Inflammatory Cytokine Production from Isolated PBMCs
To examine the inflammatory response of isolated PBMCs following exposure to elevated
concentrations of plasma PTX3 after participation in maximal exercise, isolated PBMCs were
cultured in the presence of 500 pg/mL of PTX3. Prior to exercise, no differences were observed in
the production of IL-6 and IL-10 between aerobically trained and untrained subjects following
PTX3 stimulation, whereas the PTX3-stimulated production of actTGF-β1 was significantly lower
in aerobically trained compared to untrained subjects (t

[18.056]

= -2.102, p = 0.050). Following

maximal exercise, the PTX3-stimulated production of IL-6 from isolated PBMCs was unaltered in
aerobically trained subjects and tended to decrease in untrained subjects (F [1, 28] = 2.596, p = 0.118;
Figure 4A), whereas the production of IL-10 and activated TGF-β1 significantly decreased to a
similar extent in aerobically trained and untrained subjects (F [1, 28] = 9.564, p = 0.004; F [1, 25] =
40.015, p < 0.001, respectively; Figures 4B and C).
To further assess how cardiorespiratory fitness may have influenced the inflammatory
response of isolated PBMCs following PTX3 stimulation, the relationship of relative VO2max and
PTX3-stimulated IL-6, IL-10, and actTGF-β1 production were assessed prior to and in response
to maximal exercise. While no associations were observed between relative VO2max and the PTX3stimulated production of inflammatory cytokines prior to participation in maximal exercise, a
positive association was observed between relative VO2max with the percent change in PTX3stimulated IL-6 production from isolated PBMCs (r = 0.382, p = 0.041; Figure 4D), but not IL-10
(r = -0.172, p = 0.363; Figure 4E). In addition, the association observed between relative VO2max
with the percent change in PTX3-stimulated actTGF-β1 production approached significance (r = 0.325, p = 0.098; Figure 4F).
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Finally, the relationships of plasma PTX3 and the production of PTX3-stimulated IL-6, IL10, and actTFG-β1 were examined independently in aerobically trained and untrained subjects.
Plasma PTX3 concentrations were positively associated with the production of PTX3-stimulated
IL-6 prior to participation in maximal exercise in aerobically trained subjects only (r = 0.555, p =
0.032; Figure 5A). Similarly, plasma PTX3 concentrations prior to and in response to maximal
exercise (percent change from pre- to immediately post-maximal exercise) were positively
associated with the percent change in PTX3 stimulated IL-6 production in aerobically trained
subjects (r = 0.662, p = 0.007; r = 0.625, p = 0.013, respectively; Figures 5B and C), even after
controlling for relative VO2max. No associations were observed with PTX3-stimulated IL-10 and
actTGF-β1 prior to or in response to maximal exercise.

DISCUSSION
The primary purpose of this investigation was to examine how aerobic fitness influences
the systemic and cellular PTX3 response, and in turn, the capacity of PTX3 to mediate the innate
immune response following maximal exercise. Previous research in South Korean and Japanese
subjects of all ages demonstrates that regular participation in aerobic exercise improves
cardiovascular and metabolic health by increasing resting concentrations of plasma PTX3 (Miyaki
et al., 2011; 2012; Chu et al., 2012; Zempo-Miyaki et al., 2016). To the contrary, results from the
present investigation are consistent with those presented by Huang et al. (2014), demonstrating
that aerobic fitness may not influence plasma PTX3 concentrations prior to or in response to
maximal exercise in young, healthy subjects from the United States. These findings further suggest
that factors related to geographical location and/or genetic influences may alter the capacity of
aerobic exercise training to influence plasma PTX3 concentrations. Nevertheless, our results
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demonstrate that elevated concentrations of plasma PTX3 prior to participation in acute exercise
predict a greater systemic increase in plasma PTX3 concentrations immediately upon completion
from maximal exercise, independent of aerobic training status or cardiorespiratory fitness level.
We then exposed whole blood and isolated PBMC samples to LPS, and separately to
palmitate, to examine whether or not regular participation in aerobic exercise alters the PTX3
production capacity of immune cells as a potential mechanism that may contribute to elevated
PTX3 concentrations in plasma following physiological stress (i.e., maximal exercise). As a result,
the LPS-stimulated production of PTX3 from whole blood increased equally in both aerobically
trained and untrained subjects, and despite the apparent influence of cardiorespiratory fitness, these
responses remained independent of the plasma PTX3 response in aerobically trained and untrained
subjects. Flow cytometry analysis has demonstrated that intracellular PTX3 concentrations within
neutrophils are lower following acute bouts of strenuous exercise, supporting their role as a key
contributor to the plasma PTX3 response (Nakajima et al., 2010). These results further suggest
that the increased production of PTX3 from LPS-stimulated whole blood, compared to no change
in the control conditions, may have resulted from the mobilization of circulating monocytes
capable of releasing PTX3.
To remove the potential contribution of neutrophils and the influence of leukocytosis on
the cellular PTX3 response, we examined the PTX3 production capacity of a standardized
concentration of isolated PBMCs (1.0x106 cells/mL), in which monocytes are the only cell source
to contribute to increased concentrations of PTX3 following inflammatory stimulation (Maina et
al., 2009). Our laboratory has previously demonstrated that participation in an acute bout of
submaximal aerobic exercise (70% of VO2max) reduced the net production of PTX3 from isolated
PBMCs exposed to LPS in healthy, sedentary individuals (Slusher et al., 2017a). To the contrary,
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the present study observed no differences across time or between subject groups in response to
acute maximal exercise, and despite the tendency for the LPS-stimulated production of PTX3 to
be lower in aerobically trained compared to untrained subjects (p = 0.098), there was no
relationship between this response and cardiorespiratory fitness level. Similar to the influence of
exercise intensity on the plasma PTX3 response (Nakajima et al., 2010), these results indicate that
the greater intensity of exercise (maximal vs. submaximal) may help maintain the capacity of
monocytes to synthesize and release PTX3 following exposure to elevated levels of endotoxin
observed during recovery from acute exercise. Therefore, additional analysis regarding the subset
of monocyte (i.e., classical, intermediate, and non-classical) responsible for PTX3 production and
the impact of exercise intensity on their PTX3 producing capacity would provide a necessary
explanation for gaps in the literature.
Furthermore, our laboratory recently demonstrated that exposure of PBMCs to palmitate
also increases the ex vivo production of PTX3 in healthy individuals (Slusher et al., 2016b). Thus,
we examined the influence of aerobic fitness on this cellular response prior to and immediately
following completion of maximal exercise. Notably, maximal exercise suppressed the palmitatestimulated PTX3 production capacity of PBMCs in aerobically trained, but not untrained, subjects,
a response that was negatively associated with elevated levels of cardiorespiratory fitness in all
subjects. While endotoxin and saturated fatty acids elicit an inflammatory response through similar
mechanisms (i.e., TLR4) (Pålsson-McDermott and O’Neill, 2004; Shi et al., 2006; Sindhu et al.,
2016), results from the present investigation indicate that aerobic exercise training decreases the
cellular responsiveness of monocytes exposed to palmitate following acute physiological stress.
These results suggest that additional signaling mechanisms may be involved in palmitatestimulated PTX3 production, and are differentially altered in aerobically trained and untrained
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subjects following acute exercise. Likewise, the positive associations of plasma PTX3
concentrations prior to and in response to acute maximal exercise with the decreased production
of PTX3 from isolated PBMCs exposed to LPS and palmitate observed in the trained subject group
suggests that aerobic exercise may influence the capacity of PTX3 to mediate the innate immune
response in monocytes.
To corroborate the aforementioned posit, experiment two stimulated isolated PBMCs with
physiologically relevant concentrations of PTX3 (500 pg/mL) as determined in previously reported
studies (Miyaki et al., 2011; Slusher et al., 2015; 2016b). Compared to pre exercise conditions,
maximal exercise significantly reduced the PTX3-stimulated capacity of isolated PBMCs to
produce the anti-inflammatory cytokines IL-10 and actTGF-β1. While no differences were
observed across time or between subject groups in the PTX3-stimualted production of IL-6, there
was a positive relationship observed between elevated cardiorespiratory fitness levels and the
percent change in IL-6 production from pre to immediately post maximal exercise. Upon further
investigation, plasma PTX3 concentrations were positively associated with PTX3-stimulated IL-6
production prior to and in response to maximal exercise in aerobically trained subjects only. IL-6
is typically considered a pro-inflammatory cytokine associated with increased pathology of
cardiovascular and metabolic disease (Kahn et al., 2006; Van Gaal et al., 2006). However, other
studies have shown that IL-6 exerts a variety of anti-inflammatory functions that parallel those of
PTX3, including the inhibition of LPS-stimulated pro-inflammatory cytokines and the
augmentation of anti-inflammatory cytokine production (Fattori et al., 1994; Steensberg et al.,
2003; Shiraki et al., 2016). In addition, both IL-6 and PTX3 have been shown to facilitate the
polarization of monocyte-derived macrophages from an M1 to an M2 phenotype (Fernando et al.,
2014; Pucci et al., 2014; Sun et al., 2015), supporting their anti-inflammatory function.
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Furthermore, our laboratory has recently demonstrated that despite a positive relationship between
the cellular production of PTX3 and IL-6 following LPS stimulation in healthy, aerobically
untrained subjects, these responses are independent of plasma PTX3 concentrations (Slusher et al.,
2017a). Given that IL-6 does not stimulate the cellular production of PTX3 (Breviario et al., 1992),
it may be that the PTX3 response to pro-inflammatory stimulation (e.g., IL-1β, TNF-α, LPS, and
palmitate) helps facilitate a reciprocal anti-inflammatory response (i.e., IL-6, IL-10, and actTGFβ1) from monocytes residing within the local microenvironment.
Our results support the collective body of literature to suggest that aerobic exercise and
elevated levels of aerobic fitness mediate the function of PTX3 at rest and in response to acute
exercise. As an extension upon these findings, elevated levels of aerobic fitness also appear to alter
the cellular production of PTX3 following exposure to endotoxin and saturated fatty acids prior to
and in response to acute maximal exercise, potentially enhancing the reciprocal capacity of PTX3
to mediate an anti-inflammatory response from monocytes. Future investigations should include a
more thorough examination of the intrinsic cellular function of PTX3 to provide additional insight
into the role of PTX3 as a mechanistic target to prevent and treat CVD and T2DM following
habitual participation of aerobic exercise.
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Table 1. Subject anthropometric characteristics, cardiovascular measures, and indices of
cardiorespiratory fitness
Variable
Trained (n = 15)
Untrained (n = 15) P value
Age (y)
25.27 ± 4.574
23.13 ± 3.502
0.163
Weight (kg)
69.420 ± 6.347
70.273 ± 8.709
0.761
Height (m)
1.790 ± 0.052
1.778 ± 0.082
0.621
BMI
21.681 ± 1975
22.185 ± 1.744
0.465
Waist (cm)
75.493 ± 3.098
77.333 ± 5.093
0.676
Hip (cm)
95.407 ± 3.461
96.740 ± 5.795
0.451
W:H
0.791 ± 0.027
0.780 ± 0.035
0.454
Body Fat Percentage
11.080 ± 4.096
13.440 ± 0.035
0.163
Resting HR (bpm)
60.200 ± 5.348
70.467 ± 8.943
*0.001
Resting SBP (mmHg)
117.333 ± 8.269
113.333 ± 8.997
0.215
Resting DBP (mmHg)
78.400 ± 9.891
77.067 ± 8.581
0.696
-1
4.367 ± 0.406
3.145 ± 0.491
*< 0.001
Absolute VO 2max (L·min )
-1
-1
44.793 ± 4.450
*< 0.001
Relative VO 2max (mL·kg ·min ) 63.047 ± 4.290
Note: The * indicates a significant difference between trained and untrained subjects at
baseline (p < 0.05). Data are presented as means ± S.D. BMI, body mass index; W:H,
waist-to-hip ratio; HR, Heart Rate; SBP, systolic blood pressure; DBP, diastolic blood
pressure; VO 2max , maximal oxygen uptake
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Figure 1. Plasma PTX3 concentrations at prior to and in response to acute maximal exercise in
aerobically trained and untrained subjects (panel A). The relationship of

plasma PTX3

concentrations prior to maximal exercise and the percent change in plasma PTX3 concentrations
from pre to post acute maximal exercise (panel B). # indicates a significant difference in plasma
PTX3 concentrations relative to pre exercise (p ≤ 0.05).
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Figure 2. PTX3 productions levels following LPS stimulation of whole blood (panel A) and
isolated PBMCs (panel B), or following palmitate stimulation of isolated PBMCs (panel C) in
aerobically trained and untrained subjects. The relationship of relative VO2max and culturestimulated PTX3 production under all three conditions in response to maximal exercise (percent
change from pre to immediately post maximal exercise) (panels D-F). * indicates a significant
difference in PTX3 production levels between aerobically trained and untrained subjects (p ≤
0.05). # indicates a significant difference in plasma PTX3 concentrations relative to pre exercise
(p ≤ 0.05).
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Figure 3. The relationship of plasma PTX3 concentrations prior to and in response (percent
changed) to acute maximal exercise with PTX3 productions levels following LPS and palmitate
stimulation of isolated PBMCs assessed separately in aerobically trained (closed triangle) and
untrained (open square) subjects (panels A-D).
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Figure 4. PTX3-stimulated productions of the inflammatory cytokines IL-6 (panel A), IL-10
(panel B), and TGF-β (panel C) from PBMCs isolated from aerobically trained and untrained
subjects. The relationship of relative VO2max and PTX3-stimulated inflammatory cytokine
production in response to maximal exercise (percent change from pre to immediately post maximal
exercise) (panel D-F). * indicates a significant difference in PTX3 production levels between
aerobically trained and untrained subjects (p ≤ 0.05). # indicates a significant difference in plasma
PTX3 concentrations relative to pre exercise (p ≤ 0.05).

69

Figure 5. The relationship of plasma PTX3 concentrations prior to and in response (percent
changed) to acute maximal exercise with PTX3-stimulated IL-6 productions levels from of isolated
PBMCs assessed separately in aerobically trained (closed triangle) and untrained (open square)
subjects (panels A-C).
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CHAPTER 5

INFLAMM-AGING IS ASSOCIATED WITH LOWER PLASMA PTX3 CONCENTRATIONS
AND AN IMPAIRED CAPACITY OF PBMCS TO EXPRESS hTERT mRNA FOLLOWING
LPS STIMULATION

Slusher A.L.,a* Zúñiga T.M.,a Acevedo E.O.a
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ABSTRACT
Age-related elevations in pro-inflammatory cytokines, known as inflamm-aging, are
associated with shorter immune cellular telomere lengths. Purpose: This study examined the
relationship of plasma PTX3 concentrations, a biomarker of appropriate immune function, with
telomere length in middle-aged and young adults. In addition, the capacity of isolated PBMCs to
express a key mechanistic component involved in maintaining longer telomere lengths, human
telomerase reverse transcriptase (hTERT), was examined following cellular stimulation with LPS,
PTX3, and PTX3+LPS. Methods: In 15 middle-aged (40-64 years of age) and 15 young adults
(20-31 years of age), PTX3 and inflammatory cytokines (i.e., IL-6, IL-10, TGF-β, and TNF-α)
were measured in plasma, telomere lengths were measured from isolated PBMCs, and hTERT
mRNA expression and inflammatory protein production was examined following exposure of
PBMCs with LPS, PTX3, and PTX3+LPS. Results: Aging was accompanied by the accumulation
of centrally located visceral adipose tissue, independent of changes in body weight and BMI, and
chronic alterations in the systemic inflammatory milieu (decreased plasma PTX3 and TGF-β [p =
0.009; p = 0.012, respectively]; increased plasma TNF-α [p = 0.044]). In addition, telomere lengths
were shorter in middle-aged compared to young adults (p = 0.011), and associated with increased
age and body fat percentages (r = -0.404 p = 0.027; r = -0.427, p = 0.019, respectively). Finally,
the capacity of PBMCs to express hTERT mRNA following cellular stimulation was impaired in
middle-aged compared to young adults (p = 0.033), and negatively associated with telomere
lengths (r = 0.353, p = 0.028). Conclusions: These findings suggest that aging is linked to lower
plasma PTX3 concentrations and demonstrate that the impaired capacity of PBMCs to express
hTERT mRNA may contribute to age-related shortening of telomere lengths.
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INTRODUCTION
Aging is accompanied by the chronic, low-grade elevation of circulating pro-inflammatory
cytokines (i.e., interleukin 6 [IL-6] and tumor necrosis factor alpha [TNF-α]) that typically
manifests during middle age (40-64 years of age) (Álvarez-Rodríguez et al., 2012; MorrisetteThomas et al., 2014). This phenomenon has recently been termed inflamm-aging (Franceschi et
al., 2000). While the causes of inflamm-aging are numerous (Franceschi and Campisi, 2014), the
pathology has been hypothesized to derive from the natural loss of subcutaneous adipose tissue
(SAT) and the accumulation of centrally located visceral adipose tissue (VAT) that occurs in the
absence of weight gain or changes in body mass index (BMI) (Kuk et al., 2009; Zamboni et al.,
2014). Within the stromal vascular fraction of VAT, the number of T cell lymphocytes increase,
and resident monocyte-derived macrophages are polarized towards an M1, pro-inflammatory,
phenotype (Wu et al., 2007; Cartier et al., 2009; Starr et al., 2009; Lumeng et al., 2011). As a
result, the increased production and secretion of circulating pro-inflammatory cytokines contribute
to the increases risk of premature morbidity and mortality from age-related diseases, including
cardiovascular disease (CVD) and metabolic dysregulation (Kahn et al., 2006; Van Gaal et al.,
2006).
Telomeres maintain the “youthful” function of immune cells, and shortened telomere
lengths are a biological marker of cellular aging (Benetos et al., 2001). More specifically,
telomeres are gene-poor regions located at the ends of chromosomes and are formed by thousands
of hexameric 5′(TTAGGG)n3′ repeats that protect chromosomes from degradation and end-to-endfusion (Blackburn and Gall, 1978; Moyzis et al., 1988). Although telomere lengths shorten as a
natural consequence of aging (Frenck et al., 1998; Iwama et al., 1998), the persistent exposure of
circulating immune cells (i.e., T cell lymphocytes and monocytes) to age-related pro-inflammatory
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profiles is thought to enhance the rate of telomere attrition (Merino et al., 2011; O’Donovan et al.,
2011; Hearps et al., 2012; Jurk et al., 2014). Once telomeres reach a critically shortened length,
immune cells enter an irreversible state of replication-induced cellular senescence (Hermann et al.,
2001; d’Adda di Fagana et al., 2003; Zou et al., 2004). These aged immune cells exhibit a
senescent-associated secretory phenotype (SASP) that further elevate levels of pro-inflammatory
cytokines at rest and following exposure to inflammatory stimulants, such as the gram-negative
endotoxin lipopolysaccharide (LPS) (Coppé et al., 2008; Minamino et al., 2009; Merino et al.,
2011). More worrisome may be that cellular senescence also spreads from cell to cell and other
organ systems, including adipose tissue (Tchkonia et al., 2010; Nelson et al., 2012), exacerbating
the progression of the inflamm-aging phenotype associated with age-related diseases (Minamino
et al., 2009; Merino et al., 2011; Baker et al., 2012; Jurk et al., 2014; Spyridopoulos et al., 2016).
Prior to senescence, leukocytes express human telomerase reverse transcriptase (hTERT),
the rate-limiting component and surrogate marker of the telomerase enzyme that is recruited to
facilitate the generation of new telomeric DNA necessary to maintain the length and structural
integrity of telomeres (Grieder et al., 1989; Yu et al., 1990; Kyo et al., 1998; Akiyama et al., 2002).
In response to acute inflammatory challenge, hTERT mRNA expression is significantly increased
in the THP-1 macrophage cell line following stimulation with LPS and other pro-inflammatory
stimulants (Gizard et al., 2011). Interestingly, basic cell line research demonstrates that the
capacity of leukocytes to express hTERT mRNA decreases with each cell replication (Röth et al.,
2003), suggesting that the progressive and persistent inflammatory assault observed with inflammaging may also impair the capacity of leukocytes to express hTERT mRNA in middle-aged
compared to young adults. Consequently, the decreased capacity of leukocytes to express hTERT
has been shown to be a central factor associated with telomere length shortening and the induction
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of cellular senescence (Gizard et al., 2011; Ramunas et al., 2015). However, the hypothesis that
age-related changes in adiposity, independent of changes in body weight and BMI, are associated
with chronic, low-grade elevations of pro-inflammatory cytokines which alter the length of
telomeres and associated mechanisms (i.e., hTERT) has yet to be thoroughly investigated in
healthy human adults. Such gaps within the literature highlight the need to examine hTERT as a
potential cellular target which links the mechanistic consequences of inflamm-aging to telomere
length-dependent replication-induced cellular senescence.
Pentraxin 3 (PTX3) is a counterregulatory protein that is expressed and secreted from
isolated leukocytes in concert with various inflammatory proteins (e.g., IL-6, IL-10, TGF-β, and
TNF-α) following LPS-stimulation (Lee et al., 1990; Imamura et al., 2007; Maina et al., 2009;
Slusher et al., 2017a). Although PTX3 is commonly associated with acute inflammatory insult,
PTX3 is required to prevent over activation of the inflammatory signaling pathway and elevated
concentrations of plasma PTX3 are considered an indicator of appropriate immune function in
young, healthy adults (Yamaskai et al., 2009; Shiraki et al., 2016; Slusher et al., 2016a; 2017a;
2017b). In addition, Pavanello et al. (2017) have recently demonstrated that elevated
concentrations of plasma PTX3 are associated with longer telomere lengths in healthy middleaged adults. Less is known about whether or not plasma PTX3 concentrations are altered as a
consequence of inflamm-aging, and how PTX3 may potentially be associated with the proinflammatory milieu that impairs telomeric-associated mechanisms. Therefore, age-related
changes in plasma PTX3 concentrations and its relationship with telomere length will be examined
in middle-aged (40-64 years of age) and young adults (20-31 years of age). In addition, the capacity
of PTX3 to mediate the LPS-induced inflammatory response and hTERT mRNA expression in
PBMCs isolated from middle-aged and young adults will also be examined.
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METHODS
Research Participants
A total of thirty healthy young (n = 15; between 20 and 31 years of age) and middle-aged
(n = 15; between 40 and 64 years of age) adults were recruited to participate in this study. All
subjects presented with a BMI associated with a reduced risk of CVD according to Stevens et al.
(1998). Prior to their enrollment, each subject provided their informed consent and completed a
medical history questionnaire to verify that they had not been previously diagnosed with any
cardiovascular, metabolic, renal, liver, pulmonary, asthmatic, rheumatic, or other inflammatory
disease/condition, were not currently under the administration of medication known to alter their
inflammatory or metabolic profiles, or within the past 10 years, had not been diagnosed with any
cancer requiring radiation or chemotherapy treatment. Furthermore, subjects who were currently
using or have used tobacco products within the past six months or who consumed > 10 alcoholic
beverages per week on average were excluded from participation in the study. Finally, all subjects
completed a 7-day International Physical Activity Questionnaire to verify that they participated in
≤ 150 minutes of moderate to vigorous physical activity per week (Craig et al., 2003), and were
therefore classified as physically inactive according to the American College of Sports Medicine
(ACSM, 2013). The University’s Institutional Review Board approved the study.

Laboratory Procedure
Subjects arrived at the laboratory between 6:30 and 8:30 o’clock in the morning following
an overnight fast of at least eight hours. In addition, each subject abstained from alcohol, caffeine
intake, and moderate-to-vigorous physical activity for at least 24 hours prior to their participation.
Immediately upon arrival, anthropometric measures were obtained, including an assessment of
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height and weight to determine BMI in kilograms per meters squared (kg/m2), waist and hip
circumferences to determine waist-to-hip ratio (W:H ratio), body fat percentage (BF%) evaluated
by air displacement plethysmography from measured lung volume using the BOD POD (Cosmed;
Chicago, IL, USA), and sagittal diameter of the abdominal region at the level of the L4/L5
vertebrae to determine an indirect measurement of VAT (Kvist et al., 1988). Each subject was then
provided a quite resting place for at least 10 minutes to assess resting heart rate and blood pressure.

Plasma Protein Analysis
Whole blood samples were drawn into K2EDTA tubes (BD Vacutainer, Franklin Lakes,
NJ) from each subject’s antecubital vein under quiet resting conditions. Blood samples were
immediately centrifuged at 3000 RPM for 20 minutes at room temperature. Plasma supernatants
were collected and stored at -80°C in cryopreservation tubes for the future analysis of plasma
PTX3 and TGF-β by enzyme-linked immunosorbent assay (ELISA) kits and plasma IL-6, IL-10,
and TNF-α using high-sensitivity ELISA kits according to manufacturer’s instructions (R&D
Systems, Minneapolis, MN, USA).

DNA Isolation and Measurement of Relative Telomere Length
The remaining buffy coat was collected, brought to a 5 mL volume with saline, and diluted
PBMCs were layered over equal volumes of Ficoll-Paque (ρ = 1.077 g/mL; Sigma-Aldrich, St.
Louis, MO) for a 30-minute centrifugation at 400·g at room temperature. Isolated PBMCs were
washed with saline three times, and pelleted cells were lysed in TRIzol (Thermo Fisher, Waltham,
MA, USA) for the isolation DNA according to manufacturer’s instructions. Isolated DNA was
quantified by spectrophotometry using the NanoDrop 2000 (Thermo Scientific, Wilmington, DE,
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USA). A 15 µL reaction of 2x SYBR green master mix (QuantaBio, Beverly, MA, USA), nuclease
free water, target primers (Integrative DNA Technologies, Skokie IL, USA), and a 15 µg sample
of total DNA were utilized to quantify relative telomere length by assessing the ratio of telomere
repeats (Tel 1b: 270 nM 5′-GGTTTTTGAGGGTGAGGGTGAGGGTGAGGGTGAGGGT-3′;
Tel 2b: 900 nM 5′-TCCCGACTATCCCTATCCCTATCCCTATCCCTATCCCTA-3′) to the
36B4 reference gene (36B4u: 300 nM 5′-CAGCAAGTGGGAAGGTGTAATCC-3′; 36B4d: 500
nM 5′-CCCATTCTATCATCAACGGGTACAA-3′) (T/S ratio) using PCR methodologies in
triplicate (Cawthon et al., 2002). Amplification conditions for RNA detection were set to heat
activation at 95°C for 2 minutes, followed by 40 cycles of denaturation at 95°C for 15 seconds and
annealing at 54°C for 2 minutes. For 36B4 PCR, primers were incubated as above, followed by 40
cycles of denaturation at 95°C for 15 seconds and annealing at 58°C for 1 minute. Standard curves
and dissociation curves for each primer set were performed to ensure equal efficiencies and single
product formation, respectively. Relative T/S ratios were calculated according to Cawthon et al.
(2002). Finally, the intra-assay coefficient of variation between triplicate samples was 2.24 and
1.31% for the telomere and 36B4 gene, respectively.

RNA Isolation and Measurement of hTERT mRNA Expression
A separate sample of isolated PBMCs were manually counted by hemocytometer, and
cultured in complete RPMI 1640 media supplemented with 5% fetal bovine serum and 1%
penicillin and streptomycin in the presence of LPS (10 ng/mL from E. coli O55:B5; Sigma Aldrich,
St. Louis, MO, USA), recombinant human (rh) PTX3 (100 ng/mL; R&D Systems, Minneapolis,
MN, USA), or a combination of rhPTX3 and LPS (initiated by a 30-minute pre-incubation period
with rhPTX3). Unstimulated samples served as a time-course control. Stimulated cell samples
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were incubated at 37°C with 5% CO2 for a 4-hour period at a final concentration of 2·106 in a 6well culture plate. Following the completion of the 4-hour culture period, PBMCs were
homogenized with TRIzol (Thermo Fisher, Waltham, MA, USA) and centrifuged for 2 minutes at
16,000·g in QIAshredder mini spin columns (Qiagen, Hilden, Germany) to reduce DNA
contamination from cell extracts. RNA was then fully isolated using TRIzol methods according to
manufacturer’s instruction and quantified by spectrophotometry using the NanoDrop 2000
(Thermo Scientific, Wilmington, DE, USA). A total of 1 µg of RNA was synthesized into cDNA
according to manufacturer’s instructions (QuantaBio, Beverly, MA, USA), and a 15 µL reaction
of 2x SYBR green master mix (QuantaBio, Beverly, MA, USA), nuclease free water, target
primers (Integrative DNA Technologies, Skokie IL, USA), and a 10 µg sample of cDNA were
aliquoted into a 96-well plate. Each sample was analyzed for changes in hTERT mRNA (500 nM
F: 5′-TACGGCGACATGGAGAACAAG-3′; 500 nM R: 5′-GGGCATAGCTGAGGAAGGTTT3′)

expression

against

the

reference

gene

GAPDH

(200

nM

F:

5′-

GAAGGTGAAGGTCGGAGTC-3′; 200 nM R: 5′-GAAGATGGTGATGGGATTTC-3′) by
qPCR methodologies in triplicate using a CFX96 TOUCH thermal cycler and analyzed using CFX
software (Bio-Rad, Hercules, CA, USA). Amplification conditions for RNA detection were set to
heat activation at 95°C for 2 minutes, followed by 40 cycles of denaturation at 95°C for 15 seconds
and annealing at 60°C for 30 seconds. All melting curve analysis were performed between 65°C
and 95°C and relative gene expression was calculated by 2-ΔΔCt method according to Livak and
Schmittgen (2001).

Ex Vivo Stimulation of Isolated PBMCs

79

Protein concentrations of PTX3, IL-6, IL-10, TGF-β, and TNF-α were determined from
cell culture supernatants from the 4-hour culture period, and separately, from a 24-hour culture
period (1·106 cells/mL) in duplicate by ELISA methods according to manufacturer’s instructions
(R&D Systems, Minneapolis, MN, USA).

Statistical Analyses
Data analyses were performed using the Statistical Package for the Social Sciences (SPSS
version 24.0). Independent t-tests were conducted to determine potential differences in
anthropometric profiles (height, weight, BMI, waist and hip circumferences and W:H ratio, BF%,
and sagittal diameter), cardiovascular health (resting heart rate, blood pressure, and mean arterial
pressure), plasma PTX3, IL-6, IL-10, TGF-β, and TNF-α concentrations, and relative telomere
lengths (T/S ratio) at rest. In addition, a two group (young adult and middle-aged adult) by four
condition (time-course control, LPS, PTX3, and PTX3+LPS) repeated measures analysis of
variance (rmANOVA) was utilized to examine differences in hTERT mRNA expression levels
following ex vivo stimulation of PBMCs following the 4-hour stimulation period in young adult
and middle-aged subjects. Likewise, differences in the capacity of PBMCs to produce PTX3 and
the inflammatory cytokines IL-6, IL-10, TGF-β, and TNF-α between young adult and middle-aged
subjects in response to 4- and 24-hour stimulation periods were examined by a two group by two
condition (PTX3) or four condition (i.e., IL-6, IL-10, TGF-β, and TNF-α) rmANOVA. If the
Mauchly’s test indicated a violation of sphericity assumptions, the degrees of freedom were
corrected by using Greenhouse-Geisser estimates. Finally, Pearson’s correlations were utilized to
examine the relationship among each variable, with application of the Benjamini-Hochberg
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method (False Discovery Rate) to correct for any limitations related to performing multiple
comparisons. Statistical significant being defined as a p-value ≤ 0.05.

RESULTS
Subject Descriptive Characteristics
Subject characteristics are presented in Table 1. Although these data demonstrate that no
differences in body weight (t [28] = 0.087, p = 0.932) or BMI (t [28] = 1.811, p = 0.081) were observed
between middle-aged and young adults, waist circumferences (t [28] = 2.166, p = 0.019), W:H ratio
(t [28] = 3.088, p = 0.003), BF% (t [28] = 4.054, p ≤ 0.0010), and sagittal diameter (t [28] = 4.081, p ≤
0.001) were significantly greater middle-aged adults. Likewise, while no associations were
observed between age and body weight (r = 0.027, p = 0.886) or BMI (r = 0.292, p = 0.117), age
was positively associated with waist circumference (r = 0.398, p = 0.029), W:H ratio (r = 0.531, p
= 0.003), BF% (r = 0.549, p = 0.002), and sagittal diameter (r = 0.674, p ≤ 0.001; Figure 1A-F).
These data support the hypothesis that the natural, healthy aging process is accompanied by the
increased accumulation of centrally located VAT that occurs in the absence of weight gain or
changes in BMI.
Furthermore, women were shorter, weighed less, had lower BMI, smaller waist and hip
circumferences and W:H ratios, and greater BF% compared to men. However, no other gender
differences were observed among the remaining variables examined.

Plasma PTX3 and Senescent-Associated Inflammatory Cytokines
Baseline concentrations of plasma PTX3 were significantly lower in middle-aged
compared to young adults (t

[23.897]

= 2.851, p = 0.009; Figure 2A). Although no differences in
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plasma IL-6 or IL-10 were observed (t [28] = 1.384, p = 0.089; t [28] = 1.303, p = 0.102, respectively),
plasma concentrations of the pro-inflammatory cytokine TNF-α were significantly greater (t [28] =
1.767, p = 0.044) and concentrations of the anti-inflammatory cytokine TGF-β were significantly
lower in middle-aged compared to young-adults (t

[28]

= 2.381, p = 0.012; Figures 2B-E). No

associations between plasma PTX3 concentrations and the senescent-associated inflammatory
cytokines were observed.

PBMC Relative Telomere Length
Relative telomere lengths (T/S ratio) analyzed from isolated PBMCs were significantly
shorter in middle-aged compared to young adults (t

[28]

= 2.421, p = 0.011; Figure 3A) and

negatively associated with increased age and BF% (r = -0.404 p = 0.027; r = -0.427, p = 0.019,
respectively; Figures 3B and C). While relative telomere lengths also tended to be negatively
associated with circulating concentrations of plasma TNF-α (r = -0.323, p = 0.082), no associations
were observed with plasma PTX3 or other senescent-associated inflammatory cytokines.

hTERT mRNA Expression
In response to ex vivo stimulation of isolated PBMCs with LPS, PTX3, and PTX3+LPS,
the capacity of middle-aged adults to express hTERT mRNA relative to the time-course control
condition was significantly impaired under all culture conditions compared to young adults (F [3,
84]

= 3.053, p = 0.033; Figure 4A). Although PTX3 did not alter the capacity of LPS to express

hTERT mRNA, pre-incubation of PBMCs with PTX3 for 30 minutes prior to LPS stimulation was
sufficient to significantly reduce hTERT mRNA expression relative to the time-course control
conditions in middle-aged adults only. Finally, changes in the LPS-stimulated hTERT mRNA
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expression (relative to the time-course control condition) were negatively associated age (r = 0.446, p = 0.007; Figure 4B) and positively associated relative telomere lengths (r = 0.353, p =
0.028; Figure 4C).

Ex Vivo Production of PTX3 and Senescent-Associated Inflammatory Cytokines from
Isolated PBMCs
The capacity of isolated PBMCs to produce PTX3 following 4- and 24-hour ex vivo
stimulation with LPS were similar middle-aged and young adults (F [1, 28] = 116.521, p ≤ 0.001; F
[1, 28] =

158.38, p ≤ 0.001; Figures 5A and B). Following the 4-hour stimulation period, the overall

production of IL-6 was significantly greater in middle-aged compared to young adults (F
56.043] =

[2.002,

5.094, p = 0.009; Figure 5C). However, these differences were present only in PTX3 and

PTX3+LPS culture conditions. Furthermore, only a condition effect was observed for IL-6
production following the 24-hour stimulation period (F [1.299, 36.358] = 25.91, p ≤ 0.001; Figure 5D).
In addition, only a condition effect was observed for the production of TNF-α (F

[1.602, 44.849]

=

41.682, p ≤ 0.001; F [2.201, 61.630] = 57.628, p ≤ 0.001, respectively; Figures 5E and F) and IL-10 (C
F [1.261, 35.31] = 5.771, p ≤ 0.016; F [2.293, 64.211] = 75.961, p ≤ 0.001, respectively: Figures 5G and H)
following the 4- and 24-hour stimulation periods. Finally, there was a significant increase in TGFβ following the 4-hour stimulation period in both groups (F [2.064, 57.786] = 8.605, p ≤ 0.001; Figure
5I), whereas PTX3 significantly increased TGF-β following the 24-stimulation period in young
adults only (F [1.722, 48.206] = 3.912, p = 0.032; Figure 5J).

DISCUSSION
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This study is the first to demonstrate that the natural, healthy aging process is associated
with the accumulation of centrally located VAT, independent of changes in body weight and BMI,
and basal alterations in the systemic inflammatory milieu (decreased plasma PTX3 and TGF-β;
increased plasma TNF-α). In addition, results from the present study suggest that the persistent
exposure of immune cells to a pro-inflammatory milieu may alter the length of telomeres by
impairing the capacity of isolated PBMCs to express hTERT mRNA following cellular stimulation
with LPS, PTX3, and PTX3+LPS in middle-aged compared to young adults. Changes in body
composition with age naturally favor the reduction of skeletal muscle mass, the reduced expansion
of SAT, and the increased accumulation of centrally located VAT (Kuk et al., 2009; Kohara, 2014).
In addition, alterations of adipocyte paracrine signals induce a pro-inflammatory phenotype of
resident monocyte-derived macrophages that contribute to elevated concentrations of circulating
pro-inflammatory cytokines (Lumeng et al, 2011). This phenomenon, inflamm-aging, was first
proposed in 2000 by Claudio Franceschi, stating that the human immune system evolved as a
protective mechanism for those who had historically survived up to 40-50 years of age (Franceschi
et al., 2000; De Martinis et al., 2005). However, life expectancy has significantly increased in
recent history (Riley, 2001; Oeppen and Vaupel, 2002), and it is suggested that the persistent
inflammatory stimuli from an aged immune system functioning beyond its evolutionary limits
progresses age-related inflammatory disease through the shortening of telomere lengths
(Franceschi et al., 2000; Albright et al., 2016). In support of this hypothesis, elevated plasma
concentrations of the pro-inflammatory cytokine TNF-α and decreased plasma concentrations of
the anti-inflammatory cytokine TGF-β were observed in middle-aged compared to young adults.
These findings are consistent with Álvarez-Rodríguez et al. (2012), and the lack of difference in
plasma IL-6 concentrations support the notion that plasma IL-6 is the “cytokine for gerontologists”
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with age-related differences becoming more apparent in individuals ≥ 60 years of age (Ershler,
1993; Franceschi et al., 2000; Álvarez-Rodríguez et al., 2012).
The present study also examined the impact of age on resting plasma PTX3 concentrations.
Elevated plasma PTX3 concentrations are considered an immunological biomarker associated with
the decreased risk of age-related CVD and metabolic dysfunction in otherwise healthy adults
(Yamaskai et al., 2009; Osorio-Conles et al., 2011; Slusher et al., 2016a). Similarly, although
Osorio-Conles et al. (2011) demonstrated that PTX3 mRNA expression is increased and positively
associated with the presence of pro-inflammatory protein expression in mature adipocytes isolated
from VAT, plasma PTX3 concentrations are decreased in obese compared to normal-weight
individuals. Given the similarities among obesity- and age-related changes in adipose tissue
(Tzanetakou et al., 2012), and the positive role that PTX3 has been shown to play in the regulation
of appropriate immune function and prevention of CVD and metabolic disease (Salio et al., 2008;
Norata et al., 2009; Deban et al., 2010; Slusher et al., 2016a; 2017a; 2017b), plasma PTX3
concentrations were expectedly lower in middle-aged compared to young adults. Therefore,
additional research is warranted to determine whether or not lower plasma PTX3 concentrations
during middle-age are related to morphological changes of VAT or an impairment of neutrophils,
the primary cellular source of PTX3, to synthesize and store PTX3 throughout their maturation
(Jallion et al., 2007; Alonso-Fernández et al., 2008).
Telomere lengths have previously been shown to be inversely associated with systemic
concentrations of plasma IL-6 and TNF-α in elderly adults (70-79 years old) and positively
associated with plasma PTX3 concentrations in adult nurses between 18 and 65 years of age
(Pavanello et al., 2017). The lack of a relationship between plasma IL-6 and TNF-α concentrations
and telomere lengths in the present study suggest that the link between age-related changes in
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systemic inflammatory cytokine concentrations and telomere length may become more
pronounced during the later stages of life when cellular senescence and age-related diseases are
more prevalent. In addition, the lack of a relationship of plasma PTX3 with telomere length may
be due to the physically inactive nature of the subject groups in the present study. More
specifically, Pavanello et al. (2017) compared PTX3 and telomere lengths in day-shift and nightshift nurses. While no differences in plasma PTX3 were observed between these two groups,
telomere lengths were significantly longer in night-shift nurses, who were younger and more
physically active, suggesting that the impact of physical activity on telomeres may alter the
relationship of PTX3 with telomere lengths (Miyaki et al., 2011; Loprinzi, 2015; Lopriniz et al.,
2015). Larger scale population studies may provide more insight into variables that influence the
utilization of PTX3 as an indicator of cellular health.
Data from the present study also demonstrate that the capacity of isolated PBMCs to
express hTERT is impaired in healthy, middle-aged adults. Gizard et al. (2011) have previously
shown that LPS stimulation of human macrophages significantly increases hTERT mRNA
expression. However, the capacity of cells to express hTERT decreases as cells approach their
maximum number of replications known as the Hayflick limit (Hayflick and Moorhead, 1961;
Röth et al., 2003), Ramunas et al. (2015) has recently revealed that the delivery of modified mRNA
encoding hTERT rapidly extends telomere lengths, increases cellular replication capacity, and
thus, prevents to onset of replication-induced cellular senescence in various human cell lines.
Therefore, the inability of middle-aged adults to express hTERT following inflammatory challenge
may reveal an early consequence of aging that contributes to the cascade of telomere-dependent
cellular senescence, and consequently, the development of age-related disease.
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To examine whether or not circulating immune cells exhibit characteristics of cell SASP,
isolated PBMCs were stimulation with LPS for 4- and 24-hour periods. The lack of significant
differences in the PBMC-mediated inflammatory response following ex vivo LPS stimulation
suggests that increased central adiposity, but not circulating monocytes, the primary cell type
within PBMCs to respond to LPS stimulation (Wright et al., 1990; Alles et al., 1994; Maina et al.,
2009), are the major contributor to the pro-inflammatory milieu observed in middle-aged
compared to young adults. Similarly, the lack of an elevated inflammatory response characteristic
of the SASP in middle-aged compared to young adults indicates that replication induced-cellular
senescence has yet to manifest.
In light of recent findings by Shiraki et al. (2016), demonstrating that pre-incubation of
macrophages and endothelial cells with 100 ng/mL of PTX3 can reduce the production of proinflammatory proteins (e.g., TNF-α) and increase TGF-β, the ability of PTX3 to alter the LPSstimulated hTERT mRNA expression and the production of inflammatory cytokines in PBMCs
isolated from middle-aged and young adults was also examined. Interestingly, while hTERT
mRNA expression following the pre-incubation of PBMCs with PTX3 was not different compared
to LPS alone in middle-aged or young adults, the addition of PTX3 was sufficient to suppress
hTERT mRNA expression relative to the time-course control condition in middle-aged adults only.
In addition, the pre-incubation of PBMCs with PTX3 did not differentially alter the LPSstimulated production of IL-6 and TGF-β between subject groups, whereas TNF-α production was
enhanced in both groups following the 4-hour stimulation period, and in response to the 24-hour
stimulation period, PTX3 enhanced TNF-α production in middle-aged adults and suppressed IL10 production in young adults. Although these findings suggest that although PTX3 may enhance
the “early” phase pro-inflammatory innate immune response (i.e., 4-hour), the capacity of PTX3
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to alter the pro- and anti-inflammatory arm of the “late” phase (i.e., 24-hour) innate immune
response may differ with increased age. Clearly, additional research on the influence of PTX3 to
regulate hTERT and other telomeric-related mechanisms responsible for maintaining telomere
length across the lifespan is warranted.
In conclusion, hTERT undoubtedly assumes a central role as a vital regulator of telomere
maintenance, and is potentially a novel cellular target that links the mechanistic consequences of
inflamm-aging to telomere length prior to the development of telomere-dependent cellular
senescence. However, hTERT only explained about 12.5% of the variance in telomere length in
the present study. These findings highlight the complexity of telomeric biology that is tightly
controlled by a variety of highly orchestrated and interconnected mechanisms, including the sixprotein shelterin complex and telomeric repeat-containing RNA, which regulate telomere length
through the recruitment of the telomerase enzyme (Da-Silva et al., 2010; Redon et al., 2010;
Schmidt et al., 2014; Wang et al. 2015). Therefore, future studies should consider utilizing agerelated transcriptomic changes within telomere stabilizing genes and explore their non-telomeric
functions within immune cells to help elucidate their impact on the sequela of age-related
inflammatory disease pathology at the cellular level.
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Table 1. Subject anthropometric and cardiovascular measures
Variable
Young Adult (n = 15) Middle Aged (n = 15) P value
Sex (M/F)
7/8
3/12
0.130
Age (y)
25.27 ± 3.26
57.27 ± 6.75
≤ 0.001*
Weight (kg)
66.54 ± 13.39
66.91 ± 9.94
0.932
Height (m)
1.73 ± 0.11
1.68 ± 0.07
0.141
-2
22.00 ± 2.49
23.50 ± 2.03
0.081
BMI (kg·m )
Waist (cm)
73.65 ± 8.87
80.15 ± 7.51
0.039*
Hip (cm)
99.84 ± 7.04
99.26 ± 5.95
0.809
W:H ratio
0.74 ± 0.06
0.81 ± 0.07
0.005*
Body Fat Percentage (%)
19.41 ± 6.21
28.55 ± 8.43
0.005*
Sagittal Diameter (cm)
20.08 ± 2.22
23.01 ± 2.04
0.002*
Resting HR (bpm)
67.07 ± 9.54
66.07 ± 12.66
0.809
Resting SBP (mmHg)
113.20 ± 9.375
120.13 ± 18.59
0.211
Resting DBP (mmHg)
74.40 ± 11.54
75.73 ± 10.14
0.739
MAP
87.33 ± 10.00
88.53 ± 13.25
0.782
Note: The * indicates a significant difference between middle-aged and young adults (p <
0.05). Data are presented as means ± S.D. BMI, body mass index; W:H, waist-to-hip ratio; HR,
Heart Rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial
pressure
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Figure 1. The associations of age with anthropometric characteristics in middle-aged and young
adults. These data suggest age, independent of weight gain or changes in BMI (panels A and B),
is associated with the increased accumulation of centrally located visceral adiposity, identified by
increased waist circumference, W:H ratio, body fat percentage, and sagittal diameter (panels C-F).
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difference in middle-aged compared to young adults (p ≤ 0.05).

plasma TGF-β concentrations were lower in middle-aged compared to young adults (panel E). * indicates a significant

young adults (panel C). Likewise, no differences in the anti-inflammatory cytokine IL-10 were observed (panel D), whereas

cytokine IL-6 were observed (panel B), whereas plasma TNF-α concentration were greater in middle-aged compared to

significantly lower in middle-aged compared to young adults (panel A). In addition, no differences in the pro-inflammatory

Figure 2. Plasma PTX3 and senescent-associated inflammatory cytokine concentrations. Plasma PTX3 concentrations were

Figure 3. Relative telomere lengths (T/S ratio) and the associations with age and body fat
percentage. Telomere lengths measured from isolated from PBMCs were significantly shorter in
middle-aged compared to young adults (panel A). In addition, telomere lengths were negatively
associated with increased age and body fat percentage (panels B and C). * indicates a significant
difference in middle-aged compared to young adults (p ≤ 0.05).
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Figure 4. Expression of hTERT mRNA following 4-hour stimulation of isolated PBMCs with LPS
and the associations with age and relative telomere length. hTERT mRNA expression was
impaired in middle-aged and young adults following ex vivo stimulation of isolated PBMCs with
LPS, PTX3, and PTX3+LPS (panel A). LPS-stimulated hTERT mRNA expression was negatively
associated with age (panel B) and positively associated with relative telomere lengths (T/S ratio
(panel C). * indicates a significant difference in middle-aged compared to young adults; # indicates
a significant difference compared to unstimulated control culture conditions (p ≤ 0.05).
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Figure 5. Ex vivo production of LPS-stimulated PTX3 (panels A and B) and the senescentassociated inflammatory cytokines following 4- and 24-hour stimulation of isolated PBMCs with
LPS, PTX3, and PTX3+LPS in middle-aged and young adults (panels C-J). In addition, the
capacity of PTX3 to produce and alter the LPS-stimulated production of senescent-associated
94

inflammatory cytokines ex vivo was examined. * indicates a significant difference in middle-aged
compared to young adults; # indicates a significant difference compared to unstimulated control
culture conditions; ¥ indicates a significant difference compared to LPS-stimulated culture
conditions; § indicates a significant difference compared to PTX3-stimulated culture conditions (p
≤ 0.05).
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CHAPTER 6

DISCUSSION
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Increasingly more evidence suggests that elevated plasma PTX3 concentrations serve as a
biomarker of the severity of pro-inflammatory disease. While plasma PTX3 concentrations
observed under pathological conditions have been shown to reach ≥ 100 ng/mL (Muller et al.,
2001; Mairuhu et al., 2005; Sprong et al., 2009), these values are about 50- to 200-fold higher
compared to those measured in healthy, young populations (~ 0.5 – 2 ng/mL) (Slusher et al., 2015;
2016a; 2016b). In fact, resting plasma PTX3 concentrations appear to be decreased in otherwise
healthy obese and/or middle-aged populations (Osorio-Conles et al., 2011; Slusher et al., 2015).
The role regular participation in physical activity exerts on mediating plasma PTX3 concentrations
has yet to be fully elucidated. For example, Miyaki et al. (2011; 2012a; 2014) have routinely
demonstrated that resting plasma PTX3 concentrations are elevated in physically active compared
to inactive males, and in physically active adults who were previously inactive. Likewise, elevated
plasma PTX3 concentrations are highly correlated with improved cardiovascular and metabolic
health. However, results obtained from our laboratory suggest that resting plasma PTX3
concentrations are not significantly altered with increased aerobic fitness. It is important to note
that a variety of variables may have potentially influenced these conflicting results, including
environmental and genetic influences. Therefore, future studies should consider examining the
potential influence of regular participation in physical activity across the lifespan on plasma PTX3
concentrations to better understand the utilization of PTX3 as a circulating biomarker of innate
immune function and overall immunological health. Additional areas of potential research should
also consider the identification of the major cellular source (e.g., neutrophils, adipose tissues, and
skeletal muscle) of plasma PTX3 concentrations at rest and in response to physical activity to
further identify potential target that may help restore a key component of the inflammatory milieu.
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Our laboratory has hypothesized that increased exposure of circulating immune cells to
elevated concentrations of PTX3 in plasma may help facilitate an anti-inflammatory phenotype
prior to their internalization within inflamed or damaged tissue (Slusher et al., 2016b).
Consequently, the anti-inflammatory phenotype of these immune cells may also help
counterregulate localized inflammation linked to the progression of cardiovascular or metabolic
disease pathology. While our results support the capacity of PTX3 to facilitate the production of
anti-inflammatory cytokines (e.g., IL-10 and TGF-β1), PTX3 does not appear to downregulate the
pro-inflammatory response of PBMCs following stimulation with LPS or the saturated fatty acid
palmitate under the cell culture conditions examined (Manuscripts 1 and 4). These results are in
conflict with those previously presented by Shiraki et al. (2016), suggesting that differences in our
results may be potentially due to the utilization of human cells freshly isolated from circulation
compared to immune cell lines utilized by Shiraki et al. (2016). Nonetheless, additional focus on
manipulations of PTX3 concentrations, pre-incubation strategies prior to LPS/palmitate
stimulation, and cell specific responses (e.g., differences within specific monocyte subsets and/or
monocyte-differentiated macrophage phenotype), may help further elucidate the capacity of PTX3
to mediate the cellular production of inflammatory proteins. Likewise, increased manipulations of
cellular receptors and intracellular signaling pathways that activate a wider spectrum of
transcription factors, and thus the production of a larger array of inflammatory proteins, would
potentially help elucidate how PTX3 functions within the pro- and anti-inflammatory milieu
present in individuals with various levels of health and physical fitness across the lifespan.
Finally, our results highlight that hTERT, a central mechanism involved in the maintenance
of telomere lengths, is impaired within immune cells of middle-aged compared to young adults.
Furthermore, this age-related cellular dysregulation occurs prior to the onset of cell senescence

98

and may contribute to the shortening of telomere lengths often observed during middle-age. These
findings are the first to demonstrate in humans the potential consequences of inflammatoryinduced cellular replication previously described in basic cell line research. However,
dysregulation of telomeric-associated mechanisms extends well beyond hTERT, and recent
advances in telomeric measurement techniques (e.g., Flow-FISH) and cell sequencing
methodologies (e.g., RNA-sequencing) have enabled researchers to investigate the relationship of
telomere lengths with full transcriptomic variations within specific immune cell subpopulations
and their corresponding subsets. Moreover, a recent study by Wang et al. (2017) have
simultaneously isolated DNA and RNA from the same cell to examine the relationship of telomere
length with the genomic profiles. While such methodological approaches have yet to be examined
within humans, the emphasis on understanding the molecular underpinnings that may attenuate
age-related pathology remains the next frontier of cellular physiology.
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